BD Life Sciences Preanalytical SystemsProduct catalogue
2
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and
advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organisations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family.
For more information on BD, please visit bd.com.
BD European Manufacturing and Distribution Sites Every day millions of BD Vacutainer® Blood Collection Tubes are manufactured in the UK and used worldwide.
Plymouth, United Kingdom
This plant manufactures the BD Vacutainer® range of products including blood tubes and venous access devices, and supplies markets across Europe and around the world.
European Distribution Centre in Temse, Belgium
BD in the Benelux plays a major role in the company’s ability to meet the growing demand in Eastern and Western Europe, the Middle East and Africa.
Since 2018, the Distribution centre has been expanded with a new, highly automated warehouse, bringing the total surface area covered by BD warehouses up to almost 100000 sq. m.
BD Business Segments
BD Medical
Diabetes Care
Medication Delivery Solutions
Medication Management Solutions
Pharmaceutical Systems
BD Life Sciences
Biosciences
Diagnostics Systems
Preanalytical Systems
BD Interventional
Peripheral Intervention
Surgery
Urology and Critical Care
3
Table of contents
About BD 3
The history of BD Vacutainer® systems 6BD Vacutainer® systems – A story of innovation 6
Patient safety 8 Sample management and analysis 8The BD specimen collection portfolio ensures safer care during the preanalytical phase 10BD Laboratory Consulting Services™ – helping deliver better clinical outcomes 11
Venous blood sampling 12BD Vacutainer® Evacuated Blood Collection System 12Order of draw 13Tube dimensions and sample volumes 14The BD Hemogard™ Safety Closure 15Coagulation analysis 16Serum analysis 18Plasma analysis 23Haematology 29Glucose analysis 30ESR 31Speciality tubes 32
Cell and biomarker preservation 34BD CPT™ blood collection tubes 34BD™ P100 Tubes (for stabilising proteins) 36BD™ P800 Tubes 37PAXgene® Blood ccfDNA System 38PAXgene® Blood RNA System 39PAXgene® Blood DNA System 40
Blood culture systems 42BD BACTEC™ Plastic Bottles 42BD BACTEC™ Media 42
4
Specimen collection and transport system 43BD™ ESwab™ 43
Safety blood collection sets 44
Safety blood collection needles 50
Accessories 54Adapter and holder 54Stretch tourniquets 55Blood Dispenser 55
Capillary blood sampling 56Safety lancets 56BD Microtainer® MAP Tube 58BD Microtainer® tubes 59
BD Critical Care Collection Syringes 60Blood gas syringes 60
Urine collection products 62
Transport 64
Additional information 66Product quality statement 66Labelling and packaging information 68Product code index 69
5
BD Vacutainer® systems – A story of innovation
70 years of better outcomes for patients and professionals.
1947Joseph Kleiner invents Evacutainer, the start of the BD Vacutainer® blood collection system journey
2003*BD Vacutainer®
Eclipse™ blood collection
needle with pre-attached holder
is launched 2005BD™ P100 tube andPAXgene® Blood RNA tube are launched
2006BD Microtainer™ Contact Activated Lancets are launched
2010BD Microtainer® MAP EDTA tube is launched
1950First disposable blood collection set was developed for the Red Cross
1952First BD micro lancet is launched (BD Unopette™ Products)
1964First BD Vacutainer® Heparin glass tube is launched
1993BD Microtainer®
Quikheel™ lancet is launched
1999BD Vacutainer® Eclipse™ needle is launched with
safety shield
2000*BD Vacutainer®
Citrate plastic tube is launched
2002*BD Vacutainer® Urine Preservative Tube for urinalysis is launched
1949The Evacutainer is patented
1950First glass EDTA, Serum & Oxalate Vacutainer® tubes are launched
1960BD opensBroken Bow, NE manufacturing plant
1993BD Vacutainer®
CPT™ tube is launched
1997BD Vacutainer®
PPT™ tube is launched
2000BD Vacutainer®
Stretch latex-free tourniquet is launched
2003BD Vacutainer® Push Button blood collection set is launched
2009BD Vacutainer®
P800 tubes are launched
2003*BD Vacutainer® Blood
Transfer Device and BD Vacutainer® Luer-
Lok™ Access Device (LLAD) are launched
Learn more at:
bd.com/ 70YrsHealthy
6
Thank you for trusting the BD Vacutainer® brand to enable accurate diagnostics that shape the course of care. * Approx. date shown. Varies by region WW
2013BD Sentry™ Safety Lancet is launched
2016BD Vacutainer® Barricor™ blood collection tube is launched
2018PAXgene® Blood ccfDNA tubeis launched
1970BD opens Sumter, SC manufacturing plant
1982BD opens Plymouth, UK manufacturing plant
1988BD Vacutainer®
Safety-Lok™ blood collection set is launched
1992*BD Microtainer®
Safety Flow™ lancet is launched
1975BD launches BD Vacutainer® SST™ Glass Tube (serum separation tube)
1979BD Life Sciences-Preanalytical Systems becomes its own division, called “Vacutainer Systems”
1968BD launches BD Vacutainer® Multiple Sample Straight Needles
1971BD launches BD Vacutainer® Urine Collection Tubes for culture
1977BD Microtainer® Tubes are launched for small sampling 1980
First BD Vacutainer® Citrate glass tube is launched
1988BD launches Hemogard™
closure
1990BD Vacutainer® plastic tubes are launched and most tubes
are transitioned to plastic
1993BD Vacutainer®
CPT™ tube is launched
2012BD Vacutainer® Eclipse™ Signal™ blood collection needle is launched
2016Optimised design – BD Vacutainer® Eclipse™ Signal™ blood collection needle is launched
2016BD Vacutainer® UltraTouch™ Push Buttonblood collection setis launched
2019BD Vacutainer®
brand celebrates 70th birthday
The BD Vacutainer® family of solutions focuses on delivering diagnostic accuracy, a safe environment for patient and healthcare professionals, reduced patient pain, specimen integrity and quality and total cost of ownership.
The
hist
ory
of B
D V
acut
aine
r® sy
stem
s
7
Sample management and analysis
About 2/3 of laboratory
errors occur during the preanalytical
phase 2
95% of diagnostic
delays are the result of blood collection
errors 3
Driving safe and accurate sample management and analysis throughout the patient journey
Did you know the majority of laboratory errors occur during the preanalytical phase?1
"The most commonly performed invasive medical procedure is wreaking havoc on how patients are being diagnosed, medicated and managed." Dennis J. Ernst, Director of the Center for Phlebotomy Education
Up to 70% of clinical decisions are based on laboratory data.1 Because of this, laboratory errors have a major impact on the diagnostic and treatment pathways.
The preanalytical phase, step by stepPreanalytical errors can occur at any step during the process
Storage Collection Transportation Sample prep Sample quality Analysis
Examples of preanalytical errors
Expired tube Patient ID not confirmed
Temperature out of range Incorrect label
Haemolysed sample Incorrect centrifuge
Sample Temperature > 25°C
Syringe collection Non-standard time Insufficient sample volume
Lipaemia
88
Poor sample quality contributes to errors2 that may:> cause unnecessary patient suffering4 > impact clinical outcomes6
> effect compliance to regulatory standards
160 000 patient adverse events
occur in the U.S. each year because of
misidentification 4
3.3 days
Patients spend an extra 3.3 days at the hospital after a contaminated
blood culture 5
3-12 % of hospital laboratory errors lead to adverse
events 4
Impacting patient safety by maximising, improving and standardising sample management and analysis
Maximising clinician
performance and
efficiency
Improving diagnostic accuracy
Optimising and
standardising workflows,
processes and procedures
Improve difficult vein access
Shorter fill time
Reduce patient pain
Greater treatment accuracy
Lean process
Improved sample stability
Improved traceability
Prevent needlestick injuries
Faster lab response time
Better reliability Better sample quality
Less bacterial overgrowth
1. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691–8 2. Plebani M & Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem. 1997;43(8):1348–135.3. Zwang O Albert R. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med. 2006;1(5):272–6.4. College of American Pathologists, Valenstein P, Raab S, Walsh M. Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient and specimen identification errors at
120 institutions. Arch Pathol Lab Med. 2006;130(8):1106–13.5. Bush RA, Mueller T, Sumwalt B, Cox SA, Hilfiker ML. Assessing pediatric trauma specimen integrity. Clin Lab Sci. 2010;23(4):219–22.6. Green S. Tracking the cost of poor quality and errors in preanalytical processes. Poster presented at: 63rd American Association of Clinical Chemistry Annual Conference; September, 2011; Atlanta, Georgia, USA.
Patie
nt S
afet
y
99
The BD specimen collection portfolio ensures safer care during the preanalytical phaseThe BD Vacutainer® family of products offers solutions for patient comfort, protecting healthcare professionals as well as streamlining workflow efficiency for clinical diagnostics while ensuring accuracy and reproducibility of blood analysis. These products come from the BD Vacutainer®, the gold standard in specimen collection and a leader in advancing the science of specimen collection for more than 70 years.
BD Innovative Solutions:
Specifically designed to meet emerging clinical and diagnostic
needs.
BD Microtainer® Capillary Collection System:
A complete solution designed and developed for your most fragile
patients.
BD Arterial Blood Collection System:
Provide clinically superior and safe solutions to standardise collection of arterial samples dedicated to
Critical Care Panel testing.
BD Vacutainer® Closed Urine Collection System:
Reduces mixed growth and contaminated samples saving costs, time and diagnostic and
treatment delays.
BD Vacutainer® Venous Blood Collection System:
Full range of tubes and venous access devices to meet any
laboratory and patient population needs.
1010
Preanalytical Quality Check (PAQC) / Assessment• Expert preanalytical process
examination
• Device storage, sample collection and analysis
• Understand impact of processes on quality
• Blood
• Urine
• Arterial blood gases
• Specimen transport
Product evaluation• BD white papers
• On-site product evaluation support
• Change management planning and support
Troubleshooting• On-site support
• Technical issue resolution
• Systematic approaches
Best practice training• Healthcare worker safety
• Critical care collection
• Venous blood collection
• Capillary collection
• Blood culture specimen collection
• Plasma vs Serum
• e-Learning
• Others: blood basics and basic anatomy
Accreditation support• BD AccrediWorld
• Optimised accreditation support
• Real-time support
• Customisable
Lean• Assess patient pathways
• Map value streams
• Identify issues which impact patient flow
• Reduce non-value adding activities
• Enhance predictability
BD Laboratory Consulting Services™ – helping deliver better clinical outcomes
Accreditation support
Product evaluation
Troubleshooting
Best practice training
PAQC/Assessment
Lean
Patie
nt S
afet
y
1111
Venous blood sampling BD Vacutainer® Evacuated Blood Collection System
BD Vacutainer® One Use Holder
Sterile evacuated BD Vacutainer® Barricor™ tube
BD Vacutainer® UltraTouch™ Push Button blood collection set - a safety
needle with in-vein activation
Safety valve for multiple sampling
BD Vacutainer® Eclipse™ Signal™ blood collection needle - a safety needle for venous blood sampling
• CE marked to ensure product quality
• Reproducible blood draw with each tube having a predetermined vacuum
• Comprehensive range of additives to stabilise most blood components
• BD Hemogard™ safety closure provides optimal protection for users from blood exposure
• Sterile tube and needle ensure no microbiological contamination of samples for patient safety
• A range of labels to ensure traceability of collected patient samples
The BD Vacutainer® evacuated blood collection system is the most widely-used blood stabilisation tube in the world.
12
Venous blood samplingOrder of draw
Recommendations CLSI (NCCLS), Vol. 23, No. 32, 8.10.2
With a Needle:
Others (ACD, VS, Aprotinine
and Thrombine)
With a Wingset:With Blood Culture
Blood Culture Bottles (aerobic, anaerobic)
Others (ACD, VS, Aprotinine
and Thrombine)
With a Wingset:Without Blood Culture
Discard tube
Others (ACD, VS, Aprotinine
and Thrombine)
Recommended inversions
N/A
3-4
5-6
8-10
8-10
8-10
8-10
Veno
us b
lood
sam
plin
g
1313
Tube dimensions and sample volumes BD Vacutainer® tubes are available in three different sizes as pictured below, each with different sample volumes. Tubes for special analysis may have a different size (e.g., sedimentation tubes).
The volume given in mL on the tube refers to the amount of blood that will be taken from the patient. For tubes with a fluid additive, the final volume may deviate from this (i.e., amount of blood + additive).
Venous blood samplingTube dimensions and sample volumes
13mm x 75mm 13 mm x 100 mm 16 mm x 100 mm
1.8mL2.0mL2.5mL2.7mL3.0mL3.5mL4.0mL4.5mL5.0mL
3.5 mL4.0 mL4.5 mL5.0 mL5.5 mL6.0 mL7.0 mL
6.0 mL8.0 mL8.5 mL9.5 mL10.0 mL11.0 mL
Orig
inal
size
Orig
inal
size
Orig
inal
size
14
Venous blood samplingThe BD Hemogard™ Safety Closure
Designed in accordance with ISO 6710, NF EN 14820 and CLSI GP39-A6The BD Hemogard™ Safety Closure has been designed to offer the following benefits:
• Significantly reduce contact with blood on the stopper
• Protect against contact with blood around the outer rim of the tubes
• Is engineered to provide protection against splatter from aerosols produced during opening or closing
• Protects the clinician handling the tubes from contact with blood through the deep recess and long skirted design
• Is combined with a haemorepelleant coating to prevent blood from sticking to the stopper material
Different stopper material formulations are used depending upon the intended application of the tube.
Veno
us b
lood
sam
plin
g
1515
Venous blood samplingCoagulation analysis
Sodium citrate
Trisodium citrate is used as an anticoagulant for coagulation investigations. It works as an anticoagulant by forming complexes with metal ions such as calcium, thereby inhibiting the coagulation cascade. Anticoagulation with trisodium citrate is reversible.
BD Vacutainer® Citrate Tubes contain buffered trisodium citrate in accordance with recommendations:
• 0.105 M or 0.109 M of buffered trisodium citrate solution, equivalent to 3.2% trisodium citrate
• 0.129 M of buffered trisodium citrate solution, equivalent to 3.8% trisodium citrate
The blood to additive ratio is 9:1.
BD Vacutainer® Citrate Tubes are also suitable for carrying out special test procedures such as the platelet function assay PFA-100®*.
Fill line marking
The significance of the correct ratio of blood to additive for coagulation samples is well documented. The correct fill amount is critical for correct coagulation analysis. All
BD Vacutainer® plastic coagulation tubes have a mark indicating the minimum fill level.
Glass tubes
All BD Vacutainer® glass coagulation tubes have specialised internal silicone coating to minimise contact activation.
BD Vacutainer® plastic (PET/PP) Citrate Tubes
The plastic citrate tubes made from polyethylene terephthalate (PET) and polypropylene (PP) feature innovative tube geometry that minimises tube headspace and associated platelet activation to optimise activated partial thromboplastin time (APTT) monitoring of unfractionated heparin patients.
BD Vacutainer® Citrate Tubes combine the following advantages:
• Clinically equivalent performance to the recognised global “Gold Standard”: the 4.5 mL BD Vacutainer® glass buffered citrate tube1,2.
• Clinically proven in multi-centre clinical trials for coagulation testing across all major patient populations.
• Evaluated with the most widely used coagulation analytical systems.
* PFA-100 is a registered trade mark of Siemens.1. BD Ref. VS5936: Evaluation of BD Vacutainer® Plus 2.7 and 1.8mL Sodium Citrate Coagulation Tubes Using The ELECTRA 1400c™ Analyser. BD, Franklin Lakes, NJ, USA November 20012. BD Ref. VS5966: Evaluation of 0.109M BD Vacutainer® Plus Plastic and 0.105M BD Vacutainer® Glass Sodium Citrate Tubes for PT and APTT Using the Sysmex CA - 1500 Analyzer. BD,
Franklin Lakes, NJ, USA June 2002
Clinically equivalent
performance to the recognised
golden standard
*According to CLSI Guideline, Dec 2010, Doc. GP39-A6 (replaces H01-A6)
BD Vacutainer® Plastic Citrate Tube draw volume guide
Maximum fill*
2.7 mL draw tube 13 mm x 75mm full draw
1.8 mL draw tube
13 mm x 75 mm full draw
Minimum fill indicator
1616
BD Vacutainer® Citrate tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
363047 1.8 13 x 75 Trisodium Citrate (0.109M, 3.2%) None PET/PP Paper BD Hemogard™
368273 1.8 13 x 75 Trisodium Citrate (0.109M, 3.2%) None PET/PP See Thru BD Hemogard™
363048 2.7 13 x 75 Trisodium Citrate (0.109M, 3.2%) None PET/PP Paper BD Hemogard™
364308 2.7 13 x 75 Trisodium Citrate (0.109M, 3.2%) None PET/PP See Thru BD Hemogard™
367714 4.5 13 x 75 Trisodium Citrate (0.105M, 3.2%) None Glass Paper BD Hemogard™
366575 6.0 13 x 100 Trisodium Citrate (0.105M, 3.2%) None Glass Paper BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
Venous blood samplingCoagulation analysis
Centrifugation conditions
For coagulation analyses different plasma specifications can be obtained from the citrated blood:
• Platelet-rich plasma: 150-200 g for 5 minutes at 18-25°C
• Platelet-poor plasma: Plastic tubes: 2000-2500 g for 10-15 minutes at 18-25°C Glass tubes: 1500 g for 15 minutes at 18-25°C
• Platelet-free plasma: > 3000 g for 15-30 minutes at 18-25°C
BD recommends that glass tubes are not centrifuged at more than 2200 g in a swing-out rotor (for fixed angle rotor not more than 1300g).
Tube mixing
Citrate tubes should be gently inverted 180° and back 3-4 times.
Veno
us b
lood
sam
plin
g
1717
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
368492 2.0* 13 x 75 Silica (Clot Activator) None PET Paper BD Hemogard™
368271 2.0* 13 x 75 Silica (Clot Activator) None PET See Thru BD Hemogard™
369032 4.0 13 x 75 Silica (Clot Activator) None PET Paper BD Hemogard™
365904 4.0 13 x 75 Silica (Clot Activator) None PET See Thru BD Hemogard™
367624 5.0 13 x 75 No additive None Glass Paper BD Hemogard™
367614 5.0 13 x 75 Silicone coated None Glass Paper BD Hemogard™
368814 6.0 13 x 100 Silica (Clot Activator) None PET Paper BD Hemogard™
368815 6.0 13 x 100 Silica (Clot Activator) None PET Paper BD Hemogard™
367819 6.0 13 x 100 Silica (Clot Activator) None PET See Thru BD Hemogard™
367896 10.0 16 x 100 Silica (Clot Activator) None PET Paper BD Hemogard™
Serum tubes
Serum tubes are available in glass and plastic (PET) variants. In glass tubes the surface acts as a clot activator. In plastic tubes silica particles are added as the clot activator. These tubes are labelled with the acronym CAT (Clot Activator Tube).
Tube mixing
Both plastic and glass serum tubes should be gently inverted 180° and back 5-6 times.
Clotting times
The recommended minimum clotting time for the serum tubes is 60 minutes.
Centrifugation conditions
≤ 1300 g for 10 minutes at 18-25°C
Further information
Clinical and technical information is available on request.
BD Vacutainer® Serum tubes
All tubes are supplied in boxes of 100 / cases of 1000
Venous blood samplingSerum analysis
* These tubes can reduce the risk of haemolysis.
1818
Venous blood samplingSerum analysis
BD Vacutainer® Rapid Serum Tube (RST)
This tube combines the advantages of a thrombin-based clot activator with a gel barrier, enabling rapid results and extended stability. The main advantages of BD Vacutainer® Rapid Serum Tubes versus other tubes:
• High-quality serum production.1
• Five-minute centrifugation time after the blood sample is taken.
• Stable barrier between serum and clotted blood during transportation and storage, therefore better analyte stability.
• Workflow optimisation: short centrifugation time, sample processing and archiving in the primary tube.
• No requirement for secondary tubes, reducing the possibility of misidentification.
Clotting times
The minimum recommended clotting time for BD Vacutainer® Rapid Serum Tubes is 5 minutes.
Tube mixing
Rapid Serum Tubes should be gently inverted 180° and back 5-6 times.
Centrifugation conditions
4000 g for 3 minutes at 23-27 ºC or 2000 g for 4 minutes at 23-27 ºC or 1500-2000 g for 10 minutes at 23-27 ºC
Further information
Clinical and technical information is available on request.
BD Vacutainer® Rapid Serum tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
368774 5.0 13 x 100 Thrombin based medical clotting agent Gel PET Paper BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
BD Vacutainer® Thrombin tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
367817 4.8 13 x 75 Thrombin None PET Paper BD Hemogard™
367811 6.0 13 x 100 Thrombin None PET Paper BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
BD Vacutainer® Thrombin tubes
The thrombin-based clot activator enables rapid clotting of the blood.
Clotting times
The minimum recommended clotting time for the Thrombin tubes is 5 minutes.
Centrifugation conditions
≤ 1300 g for 10 minutes at 18-25°C
1. BD White Paper VS8133: Evaluation of Serum Quality in BD Vacutainer® Rapid Serum Tubes with BD Hemogard™ Closure, 2010
Veno
us b
lood
sam
plin
g
1919
BD Vacutainer® SST™ II Advance tubes
These tubes contain an inert gel barrier that separates the serum from the blood clot during centrifugation, preventing contamination of the serum. For example, in serum certain analytes such as potassium, phosphorus and glucose should be separated from the cells within a few hours - otherwise the results will be significantly impacted. Using BD SST™ II Advance tubes, routine analytes in clinical chemistry such as potassium are still stable after a week of storage at 2-8ºC. Clinical evaluation of special chemistries such as therapeutic drugs, proteins, peptides, steroids and vitamins demonstrates a high degree of stability within the BD SST™ II Advance.1,2,3
BD Vacutainer® SST™ II Advance tubes enable faster centrifugation times of 5 minutes at 3000 g.
The main advantages of gel tubes versus non-gel tubes are:
• Stable barrier between serum and clotted blood during transportation and storage, leading to better analyte stability.
• Better sample quality.
• Optimisation of the work flow: short centrifugation time, sample processing and archiving in the primary tube.
• No requirement for secondary tubes, reducing the possibility of mis-identification.
Clotting times
The minimum recommended clotting time for BD Vacutainer® SST™ II Advance tubes is 30 minutes.
Tube mixing
Serum Separation Tubes should be gently inverted 180° and back 5-6 times.
Centrifugation conditions
1300-2000 g for 10 minutes or alternatively, according to the BD study VS 7228 3000 g for 5 minutes at 18-25°C.4
Storage conditions
BD Vacutainer® SST™ II Advance should be stored at 4-25°C and protected from direct sunlight during storage. Cooling of the tube by or during centrifugation can affect the movement capability of the gel. The optimum separation of serum and coagulated blood is achieved at a temperature of 20-25°C.
Further information
Clinical and technical information is available on request.
1. BD White Paper VS7050: Therapeutic Drug Compatibility in BD Vacutainer® SST™ II Plus Tubes, 20042. BD White Paper VS7051: Performance of BD Vacutainer® SST™ II Plus Tubes for Special Chemistry Testing, 20043. BD White Paper VS5778: Comparison of BD Vacutainer® SST™ Plus Tubes with SST™ II Plus Tubes for Common Analytes, 20014. BD White Paper VS7228: Performance of BD Vacutainer® SST II Advance tubes at Four and Five Minute Centrifugation Times, 2004
Venous blood samplingSerum analysis
enable faster centrifugation
time5 min. at 3000 g
Acrylic based gel
2020
Venous blood sampling
Cat. no.* Draw volume (mL) Size (mm) Additives Separator Material Label Cap closure Cap colour
366882 2.5* 13 x 75 Silica (Clot Activator) Gel PET Paper BD Hemogard™
367957 3.5 13 x 75 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368498 3.5 13 x 75 Silica (Clot Activator) Gel PET See Thru BD Hemogard™
368965 3.5 13 x 75 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368966 3.5 13 x 75 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368967 3.5 13 x 75 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368879 4.0* 13 x 100 Silica (Clot Activator) Gel PET See Thru BD Hemogard™
367955 5.0 13 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
366566 5.0 13 x 100 Silica (Clot Activator) Gel PET See Thru BD Hemogard™
368968 5.0 13 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368969 5.0 13 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
368970 5.0 13 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
366444 6.0* 16 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
367953 8.5 16 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
366644 8.5 16 x 100 Silica (Clot Activator) Gel PET See Thru BD Hemogard™
366468 8.5 16 x 100 Silica (Clot Activator) Gel PET Paper BD Hemogard™
BD Vacutainer® SST™ II Advance tubes
All tubes are supplied in boxes of 100 / cases of 1000
*These tubes can reduce the risk of haemolysis.
Veno
us b
lood
sam
plin
g
2121
Serum Plasma
Serum or plasma? An old question waiting for new answers
There is an ongoing debate on what type of sample a clinical laboratory should use. While serum is still considered the gold standard and remains the required sample matrix for some assays, laboratories must consider turn-around time, which is an important metric for laboratory performance and, more importantly, plays a critical role in patient care. In addition, a body of evidence emphasises the choice of plasma samples in order to prevent modifications of some measurements due to the coagulation process and related interferences. Advantages and disadvantages of serum and plasma are discussed on the basis of current literature and evidence. In addition, data are provided on the current utilisation of the matrix (serum or plasma) in Italy and in other countries. Finally, a rational for a possible shift from serum to plasma is provided.11
1. Jones BA, Bekeris LG, Nakhleh RE, et al. Physician satisfaction with clinical laboratory services: a College of American Pathologists Q-probes study of 138 institutions. Arch Pathol Lab Med. 2009;133(1):38–43. doi: 10.1043/1543-2165-133.1.38.
2. Jones BA, Walsh MK, Ruby SG. Hospital nursing satisfaction with clinical laboratory services: a College of American Pathologists Q-Probes study of 162 institutions. Arch Pathol Lab Med. 2006;130(12):1756–61.3. Akl P, Blick KE. A case of false-positive test results in a pregnant woman of unknown HIV status at delivery. Lab Med. 2014;45(3):259–63. doi: 10.1309/LMAAGVXK05LUWOQN.4. Zweig MH, Glickman J, Csako G. Analytical interference caused by incompletely clotted serum specimens. Clin Chem. 1994;40(12):2325–6.5. Nosanchuk JS, Combs B, Abbott G. False increases of troponin I attributable to incomplete separation of serum. Clin Chem. 1999;45(5):714. 6. Mannu GS, Bhalerao A. Unrecognized pseudohyperkalaemia in essential thrombocythaemia. JRSM Short Rep. 2011;2(11):85.7. Nomura M, Nakasuji M, Nakamura M, Imanaka N, Tanaka M, Kawashima H. Pitfall in intraoperative electrolyte management for a patient with pseudohyperkalemia caused by thrombocytosis. Masui. 2009;58(10):1300–2.8. Narayanan S, Guder WG. Preanalytical Variables and Their Influence on the Quality of Laboratory Results. EJIFCC. 2001;13(1):9–12.9. Schlueter K, Nauck M, Petersmann A, Church S. Using BD Laboratory Consulting Services™ to understand the impact of the preanalytical phase on sample quality and safety, a multi country perspective. Biochem Med
(Zagreb). 2013;23(2):224.10. Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T. Blood loss from laboratory tests. Clin Chem. 2003;49(10):1651–5.11. Plebani M, Banfi G, Bernardini S, et al. Siero o plasma? Un quesito non nuovo che attende risposte nuove. Biochim Clin. 2018;42(4):277–351.
Turnaround time1-2
Before centrifugation, serum samples require between 5 to 60 minutes to coagulate and several factors affect the process.
Sample quality3-8
• Serum is an acellular sample
• Coagulation processes increase the analytical variance
• Pseudohyperkalaemia is observed
• Long-term stability is high for the majority of analytes
Fibrin Formation9
Inadequate clotting may result in fibrin formation during and after centrifugation, as well as interfering with some tests.
Sample yield10
With serum samples, 44.3% of the draw volume can be harvested.
Turnaround time1-2
The anticoagulation action of heparin allows for immediate centrifugation of the specimen.
Sample quality3-8
• Plasma contains residual cells
• Analytical variance is reduced
• Potassium values are reliable
• Analyte stability is generally shorter than in serum samples
Fibrin Formation9
Heparin prevents the coagulation process from effectively removing the cause of fibrin formation. Cold storage can activate coagulation.
Sample yield10
With plasma samples, 55.2% of the draw volume can be harvested.
Slow
45% 55%
Fast
Venous blood sampling
2222
Lithium Heparin/Sodium Heparin
BD Vacutainer® plasma tubes for clinical chemistry are available with spray-dried sodium heparin or lithium heparin additives. Heparin acts as an anticoagulant by creating a complex with antithrombin III. This complex inhibits thrombin and the activated factor X and thus prevents coagulation.
Optimal anticoagulation is achieved in these tubes by using 17 IU pharmaceutical grade heparin per mL of blood. The lithium heparin in BD Vacutainer® tubes is spray dried onto the inner walls to achieve the best possible solubility. For clinical chemistry, lithium heparin is generally preferred over sodium heparin.
Tube mixing
To avoid micro-clotting, mix the BD Vacutainer® Heparin Tube with 8-10 inversions immediately after the blood sample has been taken.
Centrifugation conditions
≤ 1300 g for 10 minutes at 18-25°C
Further information
Clinical and technical information is available on request.
All tubes are supplied in boxes of 100 / cases of 1000
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
368494 2.0* 13 x 75 Lithium heparin None PET Paper BD Hemogard™
368272 2.0* 13 x 75 Lithium heparin None PET See thru BD Hemogard™
368884 4.0 13 x 75 Lithium heparin None PET Paper BD Hemogard™
368496 4.0 13 x 75 Lithium heparin None PET See thru BD Hemogard™
367869 4.0 13 x 75 Sodium Heparin None PET Paper BD Hemogard™
368886 6.0 13 x 100 Lithium heparin None PET Paper BD Hemogard™
368889 6.0 13 x 100 Lithium heparin None PET See thru BD Hemogard™
367876 6.0 13 x 100 Sodium Heparin None PET Paper BD Hemogard™
367526 10.0 16 x 100 Lithium heparin None PET Paper BD Hemogard™
368480 10.0 16 x 100 Sodium Heparin None Glass Paper Conventional
* These tubes can reduce the risk of haemolysis.
Venous blood samplingPlasma analysis
BD Vacutainer® Heparin Tubes
Veno
us b
lood
sam
plin
g
2323
Venous blood samplingPlasma analysis
BD Vacutainer® Barricor™ Plasma Blood Collection Tube
BD Vacutainer® Barricor™ is a revolutionary new blood collection tube that delivers a consistently fast, clean and high-quality plasma sample to enable the most accurate results.
The design complements the BD Vacutainer® evacuated blood collection tubes, and continues the BD heritage of ensuring best practice in the collection, transportation and processing of blood samples.
BD Barricor™ product features have been designed to ensure optimal performance. The cutting-edge mechanical separator speeds up throughput and enables workflow optimisation by harnessing the power of plasma.
Tube mixing
To avoid micro-clotting, mix the BD Barricor™ tube with 8-10 inversions immediately after the blood sample has been taken.
Centrifugation conditions4000 g for 3 minutes3000 g for 5 minutes2500 g for 7 minutes1850 g for 10 minutesFor infectious disease testing, centrifuge at 3000 g for 10 minutes1.See www.bd.com/ifu
Further information
BD Barricor™ is supported by a constantly growing knowledge base. As of January 2019, it includes:
• 13 peer-reviewed manuscripts
• 28 posters presented at international conferences
• 25 BD white papers
Ask your local BD PAS representative for these and further technical information on BD Barricor™.
A series of webinars on BD Barricor™ and the enhancement that it brought to labs across Europe are available on this website:
http://lp.bd.com/Barricor-webinars.html
1. BD White Paper VS9236: Comparison of BD Vacutainer® Barricor™ Tubes with BD Vacutainer® PST™ II, SST™ II and Serum Tubes for Selected Diagnostic Infectious Disease Marker Assays, 2016.
Blood CollectionSeparator rests at top of tube, orientation allows blood to pass through
Blood Separation Under centrifugation, the elastomer stretches, launching the separator into the blood column
Blood SeparationSeparator uses a principle of differential buoyancy for current positioning during centrifugation
2424
Venous blood samplingPlasma analysis
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
365050 3.0 13 x 75 Lithium Heparin Mechanical separator** PET Paper BD Hemogard™
365054 3.0 13 x 75 Lithium Heparin Mechanical separator** PET See Thru BD Hemogard™
365053 3.5* 13 x 100 Lithium Heparin Mechanical separator** PET Paper BD Hemogard™
365049 4.5 13 x 100 Lithium Heparin Mechanical separator** PET Paper BD Hemogard™
365052 4.5 13 x 100 Lithium Heparin Mechanical separator** PET See Thru BD Hemogard™
365081 5.0 13 x 100 Lithium Heparin Mechanical separator** PET See Thru BD Hemogard™
365056 5.5 13 x 100 Lithium Heparin Mechanical separator** PET Paper BD Hemogard™
365057 5.5 13 x 100 Lithium Heparin Mechanical separator** PET See Thru BD Hemogard™
BD Vacutainer® Barricor™ tubes
All tubes are supplied in boxes of 100 / cases of 1000
* These tubes can reduce the risk of haemolysis.** Mechanical separator: thermoplastic elastomer (TPE) and high-density polypropylene (HDPP)
Blood Separation When stretched, channels are created around the separator allowing blood cells to flow out of the plasma – a feature that differentiates BD BarricorTM from gel tubes
Blood Separation When the centrifuge slows, the elastomer returns to its original shape forming a seal between the plasma above and blood cells below, creating a stable robust barrier
Veno
us b
lood
sam
plin
g
2525
FAST DIAGNOSISTHE ART OF BLOOD SAMPLING WITH BD BARRICOR™
Fast diagnosisFAST DIAGNOSIS
THE ART OF BLOOD SAMPLING WITH BD BARRICOR™
QUALITYTHE ART OF BLOOD SAMPLING WITH BD BARRICOR™Quality
BD Barricor™ delivers a faster time–to–result for all patients with no clotting time and
a reduction in centrifugation time of up to 7 minutes.
The BD Barricor™ mechanical separator technology delivers a leading-edge collection and analytical process by eliminating
separator artefacts that may interfere with analyte testing and that could lead to instrument downtime. This innovation helps deliver the highest diagnostic quality and patient care.
Time saving1,2
during an early phase in the analytical process
Cleaner sample3,4 with reduced cell content for accuracy and stability
+ +Increasedthroughput of centrifugation
Inert separation5,6
enhanced precision in sensitive assays as the mechanical separator does not interact with the sample
= =enhanced downstream processes
and overall turn around time (TAT)high diagnostic quality
and patient care
BD Barricor™ – added value for your lab
References see page 70.
2626
ACCURACYTHE ART OF BLOOD SAMPLING WITH BD BARRICOR™
Accuracy
BD Barricor™ is an innovative technology that provides greater confidence in the accuracy of laboratory results across a broad range of analytes enabling clinicians to
act on reliable and credible results to deliver cutting edge care and service.
Improved performance5,7,8
for sensitive assays
+Analyte stability9,10,11
serum-like performance for cell-sensitive analytes
=improved results reliability
and retest avoidance
BD Barricor™ – added value for your lab
EFFICIENCYTHE ART OF BLOOD SAMPLING WITH BD BARRICOR™
Efficiency
BD Barricor™ has been designed to ensure optimal performance across the sample and laboratory
work-flow, providing opportunities for improving the total cost of operations.
Process control2
consistent accurate results accelerate the diagnostic process
+Solid retest9,10,11
if retests are required, stable samples deliver accurate results
+Consolidation12,5,13,14
multiple assays can be performed on the same tube
=enhanced efficiency
of the laboratory workflow
Veno
us b
lood
sam
plin
g
2727
BD Vacutainer® PST™ II Tubes
These tubes contain an inert gel barrier and spray-dried lithium heparin additive. The inert barrier separates the plasma from the blood cells during centrifugation, preventing contamination of the plasma. For example, in plasma certain analytes such as potassium, phosphorus and glucose should be separated from the cells within a few hours, otherwise the results will be significantly impacted. Using BD PST™ II tubes, routine analytes in clinical chemistry such as potassium are still stable after 24 hours storage at 2-8ºC. Clinical evaluation of special chemistries such as therapeutic drugs, proteins, peptides, steroids and vitamins demonstrates a high degree of stability within BD PST™ II tubes.1-3
BD Vacutainer® PST™ II tubes enable faster centrifugation times of 5 minutes at 3000 g.
The main advantages of gel tubes versus non-gel tubes are:
• Stable barrier between plasma and clotted blood during transportation and storage, therefore better analyte stability.
• Better sample quality.
• Workflow optimisation: short centrifugation time, sample processing and archiving in the primary tube.
• No requirement for secondary tubes, reducing the possibility of misidentification.
Effects of temperature
BD Vacutainer® PST™ II tubes should be stored at 4-25°C and protected from direct sunlight during storage. Cooling of the tube by or during centrifugation can affect the movement. The optimum separation of sediment and plasma is achieved at a temperature of 20-25°C.
Tube mixing
To avoid micro-clotting, mix the BD Vacutainer® PST™ II tube with 8-10 inversions immediately after the blood sample has been taken.
Centrifugation conditions
1300-2000 g for 10 minutes at 18-25°C or alternatively, according to BD study VS 75134 3000 g for 5 minutes at 18-25°C
Further information
Clinical and technical information is available on request.
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
367374 3.0 13 x 75 Lithium heparin Gel PET Paper BD Hemogard™
368497 3.0 13 x 75 Lithium heparin Gel PET See thru BD Hemogard™
367376 4.5 13 x 100 Lithium heparin Gel PET Paper BD Hemogard™
366567 4.5 13 x 100 Lithium heparin Gel PET See thru BD Hemogard™
367378 8.0 16 x 100 Lithium heparin Gel PET Paper BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
1. BD White Paper VS5919: Comparison of BD Vacutainer® PST™ II Plastic Tubes to BD Vacutainer PST™ Plastic Tubes for 22 Routine Chemistry Analytes and 3 Cardiac (STAT) Analytes, 2003.2. BD White Paper VS5925: Analyte Stability Supports Extended Use of Plasma Collected in BD Vacutainer PST™ II Plastic Tubes, 2001.3. BD White Paper VS7597: A comparative evaluation of PST II with Lithium Heparin Plus and Serum Plus for selected hormones, therapeutic drugs, tumor markers and other chemistry analytes, 2008.4. BD White Paper VS7513: Performance of BD Vacutainer® PST™ II PLUS Tubes at Four and Five Minute Centrifugation Times, 2002.
Venous blood samplingPlasma analysis
BD Vacutainer® PST™ II Tubes
2828
Venous blood samplingHaematology
BD Vacutainer® K2EDTA tubes
EDTA
EDTA salts (ethylenediaminetetraacetic acid) are used to anticoagulate whole blood for haematological investigations, as the cellular components of the blood are particularly well preserved by EDTA. The anticoagulation is achieved by the EDTA forming complexes with metal ions such as calcium, therefore inhibiting the coagulation cascade. Anticoagulation with EDTA is irreversible.
The EDTA concentration in BD Vacutainer® tubes is 1.8 mg/mL of whole blood, as recommended by the ICSH (International Council Society of Haematology)1. The ICSH recommends
dipotassium EDTA salt (K2EDTA) for haematological investigation. BD Vacutainer® plastic (PET) tubes are available with spray dried K2EDTA and K3EDTA.
Tube mixing
To avoid micro-clotting, mix the EDTA tube with 8-10 inversions immediately after the blood sample has been taken.
Further information
Clinical and technical information is available on request.
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
368841 2.0 13 x 75 K2EDTA None PET Paper BD Hemogard™
368274 2.0 13 x 75 K2EDTA None PET See Thru BD Hemogard™
368856 3.0 13 x 75 K2EDTA None PET Paper BD Hemogard™
368499 3.0 13 x 75 K2EDTA None PET See Thru BD Hemogard™
368861 4.0 13 x 75 K2EDTA None PET Paper BD Hemogard™
367862 4.0 13 x 75 K2EDTA None PET See Thru BD Hemogard™
367864 6.0 13 x 100 K2EDTA None PET Paper BD Hemogard™
365900 6.0 13 x 100 K2EDTA None PET See Thru BD Hemogard™
367525 10.0 16 x 100 K2EDTA None PET Paper BD Hemogard™
1. International Council for Standardisation in Haematology and: Expert Panel on Cytometry, Recommendations of the International Council for the Standardisation in Haematology for Ethlyenediaminetetraacetic Acid Anticoagulation of Blood for Blood Cell Counting and Sizing, Am J Clin Patholo 1993;100: 371-372.
BD Vacutainer® K3EDTA tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
367836 2.0 13 x 75 K3EDTA None PET Block BD Hemogard™
368857 3.0 13 x 75 K3EDTA None PET Block BD Hemogard™
368860 4.0 13 x 75 K3EDTA None PET Block BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
Veno
us b
lood
sam
plin
g
2929
Glucose and lactate determination
BD Vacutainer® glucose tubes are available in Sodium Fluoride / Potassium Oxalate, Sodium Fluoride / Sodium EDTA or Sodium Fluoride / Sodium Heparin additive combinations.
Glucose values in unpreserved blood samples decrease quickly after collection as glucose is metabolised by the blood cells. The Fluoride additive stops the enzymatic activity of the glycolytic pathway.
HbA1c determination
One advantage of the Fluoride / EDTA tube over the Fluoride / Oxalate tube is that the marker HbA1c can be determined from the same tube, so no additional tube sample needs to be taken.
Tube mixing
To avoid micro-clotting, mix the BD Vacutainer® Glucose tube with 8-10 inversions immediately after the blood sample has been taken.
Centrifugation conditions
≤1300 g for 10 minutes at 18-25°C
Further information
Clinical and technical information is available on request.
All tubes are supplied in boxes of 100 / cases of 1000
Cat No. Volume (mL) Size (mm) Specification Material Label Cap closure Cap colour
368920 2 13x75 Fluoride (2.5mg/mL)/Oxalate (2mg/mL) PET Paper BD Hemogard™
368921 4 13x75 Fluoride (2.5mg/mL)/Oxalate (2mg/mL) PET Paper BD Hemogard™
368201 5 13X100 Fluoride (2.5mg/mL)/Oxalate (2mg/mL) PET Paper BD Hemogard™
368520 2 13x75 Fluoride (1.5mg/mL)/EDTA (3mg/mL) PET Paper BD Hemogard™
368521 4 13x75 Fluoride (1.5mg/mL)/EDTA (3mg/mL) PET Paper BD Hemogard™
367764 5 13x75 Sodium Fluoride (4mg/mL)/Sodium Heparin (28IU/mL) Glass Paper BD Hemogard™
Venous blood samplingGlucose analysis
BD Vacutainer® tubes for glucose and lactate determination
3030
Venous blood samplingESR
BD Seditainer™ System
The BD Seditainer™ tubes are designed for erythrocyte sedimentation rate (ESR) determination without using sedimentation pipettes. The blood is taken directly into the BD Seditainer™ tubes and mixed by inversion 8-10 times. Immediately before the tubes are placed in the BD Seditainer™ manual ESR stand for measurement, the tubes must be mixed again. After one or two hours the results are read. The BD Seditainer™ stand holds a maximum of 10 BD Seditainer™ tubes and has a height adjustable zero mark. The measurement results achieved correspond to the Westergren method.
BD Vacutainer® Seditainer™ Manual ESR Stand
Cat. no. Description Quantity
366016 BD Seditainer™ manual ESR stand 1
BD Vacutainer® Manual ESR Tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
367740 1.6 13 x 75 Sodium citrate (0.129 M) None Glass Paper BD Hemogard™
366674 5.0 10.25 x 120 Sodium citrate (0.105 M) None Glass Paper BD Hemogard™
366666 5.0 10.25 x 120 Sodium citrate (0.105 M) None Glass Paper Conventional
All tubes are supplied in boxes of 100 / cases of 1000
BD Sedi-20™ and BD Sedi-40™ instrument supplies
Cat. no. Description Pack quantity
361545 BD Sedi-20™ instrument 1
361546 BD Sedi-40™ instrument 1
361547 DUO-MIX Mixer 1
361548 BD Sedi-20™/BD Sedi-40™ barcode reader 1
361549 BD Sedi-20™/BD Sedi-40™ printer 1
361550 BD Sedi-20™/BD Sedi-40™ paper printer 5
361555* ACCU-SED® normal control kit and abnormal control kit 4
* Recommended QC materials for BD-Sedi 20™ & BD Sedi-40™ control ranges. DUO-MIX and ACCU-SED® are trademarks of Eliteh Group BV.
BD Vacutainer® Seditainer™ Tubes for use with the BD Sedi-20™ and BD Sedi-40™ Systems
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
366676 1.8 8 x 100 Sodium citrate (0.105 M) None Glass Paper Conventional
Veno
us b
lood
sam
plin
g
3131
BD Vacutainer® Crossmatch tubes
BD Vacutainer® Crossmatch tubes are available with either EDTA or clot activator additives. The BD Vacutainer® Crossmatch tube is identified by:
• a pink cap
• large block label
BD Vacutainer® Crossmatch tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
366164 4.0 13 x 75 K2EDTA (Spray) None PET Crossmatch BD Hemogard™
367941 6.0 13 x 100 K2EDTA (Spray) None PET Crossmatch BD Hemogard™
368817 6.0 13 x 100 Silica (Clot Act) None PET Crossmatch BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
All tubes are supplied in boxes of 100 / cases of 1000
BD Vacutainer® K3EDTA / Aprotinin tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
361017 5.0 13 x 75 Aprotinin (250 IU) / K3EDTA None Glass Paper BD Hemogard™
BD Vacutainer® K3EDTA tubes contain Aprotinin, a protein stabiliser
Venous blood samplingSpeciality tubes
All tubes are supplied in boxes of 100 / cases of 1000
BD Vacutainer® EST™
BD Vacutainer® EST™ has no additives and is suitable as a secondary tube for anti-coagulated blood samples, for example for taking plasma samples from blood bags. The EST can also be used as a discard tube.
BD Vacutainer® EST tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
362725 3.0 13 x 75 No additive None PET See Thru BD Hemogard™
364917 11.0 16 x 100 No additive None PET Paper BD Hemogard™
3232
Venous blood samplingSpeciality tubes
Blood group determination
The anti-coagulant Acid Citrate Dextrose (ACD) is used for erythrocyte conservation. ACD is available in two solutions, A and B, each with different mixture ratios.
Anti-coagulant ACD solution A ACD solution B
Na3 citrate 3.30 mg/mL 1.89 mg/mL
Citric acid 1.20 mg/mL 0.69 mg/mL
Dextrose 3.68 mg/mL 2.10 mg/mL
Potassium sorbate 0.03 mg/mL 0.03 mg/mL
The figures represent the final concentration in the blood in each case.
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
366645 8.5 16 x 100 ACD solution A None Glass Paper Conventional
367756 6.0 13 x 100 ACD solution B None Glass Paper BD Hemogard™
All tubes are supplied in boxes of 100 / cases of 1000
BD Vacutainer® Trace Element Tube Contamination Upper LimitsAnalyte Glass µg/L PET µg/L Analyte Glass µg/L PET µg/L
Antimony 0.8 -* Lead 2.5 0.3Arsenic 1.0 0.2 Magnesium 60 40Cadmium 0.6 0.1 Manganese 1.5 1.5Calcium 400 150 Mercury** - 3.0Chromium 0.9 0.5 Selenium - 0.6Copper 8.0 5.0 Zinc 40 40Iron 60 25
* BD Vacutainer® trace element PET tubes should not be used for antimony testing.
** Water extraction analysed by cold vapour, all others ICP-MS
Trace element determination
BD Vacutainer® tubes for trace element determination contain controlled amounts of trace elements for trace element analysis. Maximum concentrations are defined for the trace elements antimony, arsenic, lead, chromium, iron, cadmium, calcium, copper, magnesium, manganese, mercury, selenium and zinc that could be extracted by blood from the tube itself or the stopper.
Every production batch is checked and only released if the given maximum value is not exceeded. The values given take into account the use of a straight BD needle.
BD Vacutainer® Tubes for Blood Group Determination
All tubes are supplied in boxes of 100 / cases of 1000
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
368380 6.0 13 x 100 Silica (clot activator) None PET Paper BD Hemogard™
368381 6.0 13 x 100 K2EDTA None PET Paper BD Hemogard™
367735 7.0 13 x 100 Sodium heparin None Glass Paper BD Hemogard™
BD Vacutainer® Tubes for Trace Element Determination
Veno
us b
lood
sam
plin
g
3333
Cell and biomarker preservationBD CPT™ blood collection tubes
BD CPT™ (Cell Preparation Tube)
The BD CPT™ contains FICOLL™* and is a one-step system to provide a simple method for isolating Peripheral Blood Mononuclear Cells (PBMC) - lymphocytes and monocytes from whole blood.
The tube provides a sample-to-yield solution, eliminating stages of blood transfer, preparation of FICOLL™, and manual gradient separation. Waiting time is significantly reduced as centrifugation can be carried out with the brakes enabled.
The tube can yield up to 15 million PBMCs with centrifugation times of 15 or 20 minutes. The BD CPT™ tube enables:
• Preparation and consistency- Standardised process when compared to manual
FICOLL™ gradient separations- Reproducibility between sample preparations and
technical operators- Less blood exposure for laboratory staff
• Faster separations- Blood draw to centrifuge - FICOLL™ is contained in the
tube enabling fast gradient separation- Reduce waiting times during centrifugation with
brakes enabled
• Post separation- The gel barrier provides clear cell separation and
prevents re-mixing- Transport of separated sample can be used in the
primary CPT tube- Cells are stable in the primary tube for up to 24 hours,
depending on down stream application
The BD CPT™ tube is CE marked for in vitro diagnostic use.
Tube mixing
Cell Preparation Tubes should be gently inverted 180° and back 8-10 times.
Further information
Clinical and technical information is available on request.
Centrifugation conditions
Sodium Heparin 1500-1800 g for 15 minutes at 18-25°C
Sodium Citrate 1500-1800 g for 20 minutes at 18-25°C
* FICOLL is a registered trademark of GE Healthcare Companies.** Please note: These tubes are longer than conventional blood collection tubes. Please ensure that the tubes are free to swing when placing them into the centrifuge.
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
362781 4.0 13 x 100 Sodium Citrate 0.45mL 0.1M / 1.0mL FICOLL™ Gel Glass Transparent Conventional
362782 8.0 16 x 125** Sodium Citrate 1.0mL 0.1M / 2.0mL FICOLL™ Gel Glass Transparent Conventional
362780 8.0 16 x 125** Sodium Heparin 132 USP Units in 1.0mL PBS / 2.0mL FICOLL™ Gel Glass Transparent Conventional
All tubes are supplied in boxes of 60
Available to buy online at www.bdbiosciences.com - search CPT
BD Vacutainer® CPT™ tubes
3434
Cell and biomarker preservationBD PPT™ blood collection tubes
BD PPT™ (Plasma Preparation Tube)
The BD PPT™ tube is used for the separation of undiluted plasma from whole blood for molecular diagnostic test methods. These methods include, but are not limited to, polymerase chain reaction (PCR) or branched DNA (bDNA) amplification techniques. The BD PPT™ tube is also applicable to other MDx analysis where an undiluted plasma specimen is required. The BD PPT™ tube ensures:
• Safe handling of infectious samples The user is not exposed to blood samples enclosed in the BD Vacutainer® tube. Plasma is prepared in the closed BD Vacutainer® tubes that can be directly transported, eliminating the need for aliquoting from primary BD Vacutainer® tube to secondary container and re-labelling.
• Plasma quality is maintained The gel barrier prevents plasma from coming in contact with red blood cells to maintain stability of the plasma. Viral load will be stable for:
6 hours - whole blood at room temperature
24 hours - separated plasma at room temperature
5 days - separated plasma refrigerated at 4ºC.
Plasma may be stored frozen in situ in the BD PPT™ tube. However, freezing plasma in situ in BD PPT™ tubes may be prohibited for some assays and the assay manufacturer’s guidelines should be consulted.
The BD PPT™ tube is CE marked and FDA 510(k) approved for in vitro diagnostic use.
Tube mixing
Plasma Preparation Tubes should be gently inverted 180° and back 8-10 times.
Further information
Clinical and technical information is available on request.
Centrifugation conditions
1100 g for 10 minutes at 18-25°C
BD Vacutainer® PPT™ tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
362795 5.0 13 x 100 K2EDTA Gel PET See Thru BD Hemogard™
362799 8.5 16 x 100 K2EDTA Gel PET See Thru BD Hemogard™
All tubes are supplied in cases of 1000
Available to buy online at www.bdbiosciences.com - search PPT
Cell
and
biom
arke
r pre
serv
atio
n
3535
Cell and biomarker preservationBD™ P100 Tubes (for stabilising proteins)
BD™ P100 Plasma Protein Preservation Tubes
The BD™ P100 tube is a plasma protein preservation tube that contains K2EDTA anticoagulant and a broad spectrum protease inhibitor cocktail optimised for human blood. The BD™ P100 tube also features a mechanical separator which provides high-quality plasma suitable for many downstream protein analysis platforms including mass spectrometry and immunoassays.
The blend of broad spectrum protease inhibitors in the
BD™ P100 tube has been specifically developed and optimised for human plasma to ensure the broadest range of plasma proteins are stabilised.
The separator provides a solid barrier between plasma and cellular material, ensuring a significant reduction in cellular contamination to further increase the stability of the plasma proteins.
Centrifugation
For best sample quality, the centrifugation of the BD P100™ tube should be performed in a swing-out centrifuge as soon as possible after the blood sample has been collected. Use of a fixed 45º angle rotor is possible.
Optimum centrifugation conditions for 8.5 mL tube: 2500 g for 20 minutes
If 2500 g cannot be achieved: 1600 g for 30 minutes or 1100 g for 30 minutes
Optimum centrifugation conditions for 2.0 mL tube: 1000-3000 g for 10 minutes
The BD™ P100 plasma protein tube is for research use only. Not for use in diagnostic procedures.
Further information
Clinical and technical information is available on request.
Mechanical plasma separator (366448 only)
Beforecentrifugation
Plasma mechanical separator
Non-patient cannula, piercing the closure stopper
Blood collection set
Tube holder
Closure stopper
Aftercentrifugation
* Mechanical separator: PET, TPE and LDPE
BD™ P100 Tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
366422 2.0 13 x 75 K2EDTA/Protease inhibitor None PET Paper BD Hemogard™
366448 8.5 16 x 100 K2EDTA/Protease inhibitor Mechanical separator* PET Paper BD Hemogard™
All tubes are supplied in boxes of 24
Available to buy online at www.bdbiosciences.com - search P100
3636
Cell and biomarker preservationBD™ P800 Tubes
BD™ P800 (Plasma GLP-1, GIP, Glucagon and OXM Preservation Tubes)
The BD™ P800 tube contains a proprietary cocktail of protease, esterase and dipeptidyl peptidase IV (DPP-IV) inhibitors that immediately solubilises during blood collection. The BD™ P800 tube provides preservation of the incretin peptides released during feeding - glucagon like peptide-1 (GLP-1), gastric inhibitory peptide (GIP), glucagon and oxyntomodulin (OXM)1. The incretin peptides are associated with metabolic diseases, such as type 2 diabetes and obesity.
Centrifugation conditions
2.0 mL tubes: 1100-1300 g for 10 minutes 8.5 mL tubes: 1100-1300 g for 20 minutes
Further information
Clinical and technical information is available on request. The BD™ P800 tube is for research use only. Not for use in diagnostic procedures.
Stability
The stability of the peptides in BD™ P800 tubes in comparison to BD Vacutainer® EDTA Tubes for routine measurements is set out in the following table:
* Stable for up to 12 hours +/- 3 hours when EDTA tube is on ice Half-life, hours (at room temperature, unless specified).
Peptides T ½ EDTA (h) T ½ P800 (h)
GLP-1 (G36A) 4-24* > 96
GLP-1 (G37) 4-18 > 96
GIP (1-42) 5-20 > 96
OXM (1-37) < 24 > 72
Glucagon 5-20 > 45
BD™ P800 Tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
366420 2.0 13 x 75 K2EDTA/Protease, esterase and DPP-IV inhibitor None PET Paper BD Hemogard™
366421 8.5 16 x 100 K2EDTA/Protease, esterase and DPP-IV inhibitor None PET Paper BD Hemogard™
All tubes are supplied in cases of 100
Available to buy online at www.bdbiosciences.com - search P800
1. Yi J, Warunek D, Craft D. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens. PLoS One. 2015;10(7):e0134427.
Proprietary cocktail that
immediately solubilises
during blood collection
Cell
and
biom
arke
r pre
serv
atio
n
3737
Cell and biomarker preservationPAXgene® Blood ccfDNA System
PAXgene® Blood one word System
The PAXgene® blood ccfDNA tube (IVD) was developed by PreAnalytix, a joint venture between QIAGEN and BD.
The PAXgene® blood ccfDNA tube is a plastic, evacuated tube intended for the collection, storage and transport of human blood and stabilisation of DNA. It is a closed tube used to prepare circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from nucleated cellular fraction, and used with molecular test methods that require ccfDNA or gDNA.
The PAXgene® blood ccfDNA tube ensures:
• Immediate stabilisation of circulating, cell-free DNA, and genomic DNA for the following duration and temperature ranges: 7 days in whole blood at 2-30°C 1 day in whole blood at 37°C
• Analysis of methlyated markers A unique non-crosslinking stabilisation chemistry containing a proprietary formulation that preserves circulating, cell-free DNA without cross-linking challenges to optimise sensitivity and specificity for genetic biomarker downstream analysis*.
• ccfDNA & gDNA Extract both ccfDNA and gDNA from one tube after centrifugation for parallel analyte analysis.
• High-quality analytes for downstream analysis Compatibility of NGS and qPCR quantification methods with ccfDNA and DNA samples
• Workflow ease Simplified centrifugation protocols with an optional second centrifugation at the same speed and force to optimise workflow efficiencies at 1600 x g for 10 minutes with medium brakes.
Performance characteristics established with 18S ribosomal and DYS14 Y-chromosomal ccfDNA fragments in plasma.
For more information please visit www.PreAnalytix.com
The PAXgene® blood ccfDNA tube (IVD) is CE marked for in vitro diagnostic use.
Further information
Clinical and technical information is available on request.
NEW
* Users must validate use of product for their specific molecular diagnostic assay.
PAXgene® Blood ccfDNA Tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
768165 1.5 16 x 100 Proprietary None PET Paper with 2D barcode BD Hemogard™
All tubes are supplied in cases of 100
Available to buy online at www.bdbiosciences.com - search PAXgene ccfDNA
3838
Cell and biomarker preservationPAXgene® Blood RNA System
* The PAXgene® blood miRNA kit is for research use only (RUO)
PAXgene® Blood RNA System
The PAXgene® blood RNA tube (IVD) was developed by PreAnalytiX, a joint venture between QIAGEN and BD. The PAXgene® blood RNA system consists of the PAXgene® blood RNA tube and the PAXgene® blood RNA isolation kit available from QIAGEN.
The PAXgene® blood RNA tube contains a proprietary reagent that immediately stabilises cellular RNA. The PAXgene® blood RNA tube ensures:
• Immediate stabilisation of cellular RNA in whole blood The cellular RNA will be stable in the PAXgene® tube for: 3 days – whole blood at room temperature (18-25°C) 5 days – refrigerated whole blood (2-8°C) 8 years – frozen whole blood (–20 and –70°C)
• RNA yield The yield, dependent upon the sample and the RNA isolation kit, is ≥ 3 µg for > 95% of the samples (healthy subjects with a leukocyte count of 4.8 – 11 x 106/mL)
• RNA quality The A260/A280 ratio is 1.8-2.2 for 95% of all samples. Genomic DNA contamination is ≤ 1% in ≥ 95% of all samples
• Stabilisation of miRNA The PAXgene® blood miRNA kit*, is available from QIAGEN
• Increased traceability The PAXgene® blood RNA tube has a human readable and 2D barcode label. Each tube has a unique identification code that can be associated to the patient blood specimen
For more information please visit www.PreAnalytiX.com.
The PAXgene™ blood RNA system is CE marked for in vitro diagnostic use.
Further information
Clinical and technical information is available on request.
All tubes are supplied in cases of 100
Available to buy online at www.bdbiosciences.com - search PAXgene RNA
PAXgene® Blood RNA Tubes
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
762165 2.5 16 x 100 Proprietary None PET Paper with 2D barcode BD Hemogard™
Proprietary reagents that
immediately stabilise cellular
RNA
Cell
and
biom
arke
r pre
serv
atio
n
3939
Cell and biomarker preservationPAXgene® Blood DNA System
PAXgene® Blood DNA System
The PAXgene® blood DNA tube (IVD) was developed by PreAnalytiX, a joint venture between QIAGEN and BD. The performance of the PAXgene® blood DNA tube has been verified with automated and manual DNA isolation kits available from QIAGEN using magnetic bead, silica membrane and precipitation technologies.
The PAXgene® blood DNA tube contains a proprietary EDTA formulation that immediately stabilises intracellular DNA. The PAXgene® blood DNA tube ensures sufficient DNA quantity and quality for molecular diagnostic assays that require DNA from whole blood.
Documented DNA stability and performance data
DNA samples purified from the 2.5 mL draw volume tube will have a ratio (A260/A280) of 1.7-1.9 and a DNA concentration of ≥ 12.5 ng DNA/µl eluate for 95% of samples and ensure DNA stability after blood collection for:
14 days at room temperature (18-25°C) refrigerated for 28 days (2-8°C) 3 days at 35ºC
Increased traceability
The PAXgene® blood DNA tube (IVD) has a human readable and 2D barcode label. Each tube has a unique identification code that can be associated with the patient blood specimen.
For more information please visit www.PreAnalytix.com.
The PAXgene® blood DNA tube (IVD) is CE marked for in vitro diagnostic use.
Further information
Clinical and technical information is available on request.
Cat. no. Draw volume (mL) Size (mm) Additive Separator Material Label Cap closure Cap colour
761165 2.5 13 x 75 K2EDTA None PET Paper with 2D barcode BD Hemogard™
PAXgene® Blood DNA Tubes
All tubes are supplied in cases of 100
Available to buy online at www.bdbiosciences.com - search PAXgene DNAProprietary
formulation that
immediately stabilises
intracellular DNA
40
Cell
and
biom
arke
r pre
serv
atio
n
4141
The lastest addition to the BD BACTEC™ range. New Plastic Blood Culture Bottles increase lab convenience while maintaining high quality standards.
• Provides the convenience of plastic without compromising clinical performance• Plastic and glass bottles can be used in the same instrument• Ready to use after a software update
Contact your BD Sales Representative today for more details.
BD BACTEC™ Media
Cat. no. Specification Unit of sales
442023 BD BACTEC™ Bottle Plastic Plus Aerobic Medium 50 vials
442022 BD BACTEC™ Bottle Plastic Plus Aerobic Medium 50 vials
442021 BD BACTEC™ Bottle Plastic Lytic Anaerobic Medium 50 vials
442020 BD BACTEC™ Bottle Plastic PEDS Plus Medium 50 vials
Blood culture systemsBD BACTEC™ Plastic Bottles
BD Diagnostics, a leader in blood collection and blood culture for more than 40 years, offers clinicians and microbiology laboratories a unique unmatched range of solutions providing:• Safe specimen collection and transport • Compatible, high-performing diagnostic systems • Tools for active and real-time reporting • High-quality trainings and support
Please contact your local BD office for more details or find more information on http://www.bd.com/europe/ds/
BD BACTEC™ Media
Cat. no. Specification Unit of sales
442260 BD BACTEC™ - Standard/10 Aerobic/F Medium 50 vials
442192 BD BACTEC™ PLUS - Aerobic/F Medium 50 vials
442193 BD BACTEC™ PLUS - Anaerobic/F Medium 50 vials
442265 BD BACTEC™ - Lytic Anaerobic/F Medium 50 vials
442194 BD BACTEC™ - Peds Plus™ Medium 50 vials
442280 BD BACTEC™ - Myco/F Lytic Medium 50 vials
442206 BD BACTEC™ - Mycosis IC/F Medium Culture Vials 50 vials
257283 BD BACTEC™ PLUS Aerobic / Anaerobic Twinset 25 sets
BD BACTEC™ Media
4242
Blood culture systems
BD BACTEC™ Bottles compatible with BD Vacutainer® Blood collection systems
As the worldwide leader in safety-engineered medical devices, BD has designed its BD BACTEC™ blood culture bottles to be fully compatible with the widely available BD Vacutainer® safety blood collection systems – thus reducing the risk of contaminations and accidental needle-stick injuries during blood collection and sub-culturing.
For more information on the BD Vacutainer® Push Button and Safety-Lok™ blood collection sets, BD Vacutainer® holders and blood transfer device, please go to pages 44-54 in this catalogue.
BD™ ESwab™ Collection and Transport System is intended for the collection and transport of clinical specimens containing aerobes, anaerobes and fastidious bacteria from the collection site to the testing laboratory. In the laboratory, ESwab specimens are processed using standard clinical laboratory operating procedures for bacterial culture.
BD™ ESwab™
Cat. no. Specification Description Unit of sales
220245 BD™ ESwab™ Regular Collection Kit
White polypropylene screw-cap tube filled with 1 mL of Liquid Amies Medium and one regular size flocked applicator swab. 50
220246 BD™ ESwab™ Minitip Collection Kit
Green polypropylene screw-cap tube filled with 1 mL of LiquidAmies Medium and one minitip flocked applicator swab. 50
220532 BD™ ESwab™ Flexible Minitip Collection Kit
Blue polypropylene screw-cap tube filled with 1 mL of LiquidAmies Medium and one flexible minitip flocked applicator swab. 50
Specimen collection and transport systemBD™ ESwab™
Bloo
d co
llect
ion
4343
Safety blood collection sets
BD Vacutainer® UltraTouch™ Push Button Blood Collection Set
The BD Vacutainer® UltraTouch™ Push Button blood collection set employs patented PentaPoint™ comfort 5-bevel needle technology. Studies have shown that this design helps reduce the chance of a painful injection by creating a flatter, thinner surface to help penetrate the skin with significantly greater ease.1 This new safety device has been shown to reduce penetration forces by up to 32 percent when compared to another leading blood collection set.2
In addition, its exclusive BD RightGauge™, Ultra-Thin wall technology allows for better blood flow due to the needle’s larger inner diameter. Therefore, clinicians can select a smaller gauge needle without sacrificing sample quality. This technology can also improve tube fill time by up to 50% when using the same gauge (a standard 23-G needle vs the BD Vacutainer® UltraTouch™ Push Button needle).3
The BD Vacutainer® UltraTouch™ Push Button blood collection set brings healthcare workers greater confidence and the ability to know they can use the needle gauge that is most appropriate for their patients with improved efficiency. Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use Holder be used.
Clinical and technical information is available on request.
1. Hirsch L, Gibney M, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328–35.
2. Mouser A, Uettwiller-Geiger D, Plokhoy E, Berube J, Jha Ahuja A, Stankovic AK. Evaluation of Pain and Specimen Quality by Use of a Novel 25-Gauge Blood Collection Set With Ultra-thin Wall Cannula and 5-Bevel Tip Design. J Appl Lab Med. 2017;2(2):201–210.
3. BD White Paper VS9249: BD Vacutainer® Push Button Blood Collection Set Tube Fill Time, 2016.
Reduce needlestick injury
Lower pain compared to traditional blood collection sets
In-vein confirmation results in ease of use and confidence during venous blood collection
Improving difficult
venous access
Faster fill time compared to traditional
blood collection sets
The experience
4444
PentaPoint™ needle tip
Comfort SpeedThin wallUltra-thin wall
41
23
5
All measurements are in mm
23 G
0.3810.533
0.600
0.3050.406
25 G 0.500
21 G
0.5470.645
0.800
Safety blood collection sets
1.BD White Paper VS9381: Evaluation of Draw Volume, Fill Time and Fill Rate for BD BACTEC™ Blood Culture Bottles Using the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set Compared to the BD Vacutainer® Push Button Blood Collection Set, 2019.
BD Vacutainer® UltraTouch™ Push Button Blood Collection Sets
Cat. no. Size Needle length Length of tubing With Luer adapter Colour code Box/Case
367393 21 G (0.8 mm) 19 mm 178 mm Yes 50/200
367365 21 G (0.8 mm) 19 mm 305 mm Yes 50/200
367392 23 G (0.6 mm) 19 mm 178 mm Yes 50/200
367364 23 G (0.6 mm) 19 mm 305 mm Yes 50/200
367391 25 G (0.5 mm) 19 mm 178 mm Yes 50/200
367363 25 G (0.5 mm) 19 mm 305 mm Yes 50/200
BD Vacutainer® UltraTouch™ Push Button Blood Collection Sets with Pre-Attached Holder
Cat. no. Size Needle length Length of tubing Colour code Box/Case
368686 21 G (0.8 mm) 19 mm 178 mm 20/100
368689 21 G (0.8 mm) 19 mm 305 mm 20/100
368685 23 G (0.6 mm) 19 mm 178 mm 20/100
368688 23 G (0.6 mm) 19 mm 305 mm 20/100
368684 25 G (0.5 mm) 19 mm 178 mm 20/100
368687 25 G (0.5 mm) 19 mm 305 mm 20/100
BD Vacutainer® Ultratouch™ Push Button Blood Collection Set with Pre-Attached Holder
With this safety blood collection set the holder is already pre-attached, so it is not necessary to manually assemble the needle and holder. This ready-for-use blood collection set is individually packaged in a sterile blister.
This sterile closed system is ideally suited for taking of samples using the BD BACTEC™ blood culture bottles with improved fill rate1.
NEW
Bloo
d co
llect
ion
4545
Safety blood collection sets
BD Vacutainer® Push Button Blood Collection Set
The BD Vacutainer® Push Button blood collection set with in-vein activation offers split-second protection against needlestick injuries.
• Indication of successful venepuncture: When the vein has been successfully penetrated, blood flows immediately into the inspection chamber.
• Versatile: For taking blood samples and for short-term infusions of up to 2 hours.
• Single-handed activation possible: Activating the safety mechanism with one hand allows you to focus more attention on the patient and the venepuncture site.
• Protection against needle injuries: When pressing the button, the needle is withdrawn straight from the vein and disappears permanently inside the housing of the blood collection set. This provides an extremely high level of protection against needle injuries1.
Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use Holder is used.
Clinical and technical information is available on request.
Cat. no. Size Needle length Length of tubing With Luer adapter Colour code Box/Case
367338 21 G (0.8 mm) 19 mm 178 mm Yes 50/200
367344 21 G (0.8 mm) 19 mm 305 mm Yes 50/200
367326 21 G (0.8 mm) 19 mm 305 mm No 50/200
367336 23 G (0.6 mm) 19 mm 178 mm Yes 50/200
367342 23 G (0.6 mm) 19 mm 305 mm Yes 50/200
367324 23 G (0.6 mm) 19 mm 305 mm No 50/200
367335 25 G (0.5 mm) 19 mm 178 mm Yes 50/200
367341 25 G (0.5 mm) 19 mm 305 mm Yes 50/200
367323 25 G (0.5 mm) 19 mm 305 mm No 50/200
BD Vacutainer® Push Button Blood Collection Sets
1. Hotaling MA. retractable winged steel (butterfly) needle performance improvement project. JT Comm Qual Patient Saf. 2009;35(2):100–105.
4646
Safety blood collection sets
BD Vacutainer® Push Button Blood Collection Set with Pre-Attached Holder
With this safety blood collection set, the holder is already pre-attached, so it is not necessary to manually assemble the needle and holder. This ready-for-use blood collection set is individually packaged in a sterile blister.
This sterile closed system is ideally suited for taking of samples using the BD BACTEC™ blood culture bottles.
Further Information
Technical information is available on request.
BD Vacutainer® Push Button Blood Collection Sets with Pre-Attached Holder
Cat. no. Size Needle length Length of tubing Colour code Box/Case
367355 21 G (0.8 mm) 19 mm 178 mm 20/100
368657 21 G (0.8 mm) 19 mm 305 mm 20/100
367354 23 G (0.6 mm) 19 mm 178 mm 20/100
368658 23 G (0.6 mm) 19 mm 305 mm 20/100
Ready- for-use
blood collection set
Bloo
d co
llect
ion
4747
Safety blood collection sets
BD Vacutainer® Safety-Lok™ Blood Collection Set
The BD Vacutainer® Safety-Lok™ blood collection set for venous blood collection has a fully integrated safety shield, which once activated, protects against needlestick injuries.
• Indication of successful venepuncture: When the vein has been successfully penetrated, blood can be seen in the device.
• Versatile: For taking blood samples and for short-term infusions of up to 2 hours.
• Single-handed activation possible: Activating the safety mechanism with one hand allows you to focus more attention on the patient and the venepuncture site.
• Protection against needle injuries: Following successful venepuncture, the integrated safety shield is pushed over the needle, covering it completely, indicated by an audible click.
Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use Holder is used.
Clinical and technical information is available on request.
BD Vacutainer® Safety-Lok™ Blood Collection Sets
Cat. no. Size Needle length Length of tubing With Luer adapter Colour code Box/Case
367282 21 G (0.8 mm) 19 mm 178 mm Yes 50/200
367286 21 G (0.8 mm) 19 mm 305 mm Yes 50/200
367246 21 G (0.8 mm) 19 mm 305 mm No 50/200
367284 23 G (0.6 mm) 19 mm 178 mm Yes 50/200
367288 23 G (0.6 mm) 19 mm 305 mm Yes 50/200
367247 23 G (0.6 mm) 19 mm 305 mm No 50/200
367295 25 G (0.5 mm) 19 mm 178 mm Yes 50/200
368383 25 G (0.5 mm) 19 mm 305 mm No 50/200
4848
Safety blood collection sets
BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder
With this safety blood collection set the holder is already pre-attached, so it is not necessary to manually assemble the needle and holder. This ready-for-use blood collection set is individually packaged in a sterile blister.
The sterile closed system is ideally suited for the taking of samples using BD BACTEC™ blood culture bottles.
Further information
Technical information is available on request.
Cat. no. Size Needle length Length of tubing Colour code Box/Case
368654 21 G (0.8 mm) 19 mm 178 mm 25/200
368652 21 G (0.8 mm) 19 mm 305 mm 25/200
368655 23 G (0.6 mm) 19 mm 178 mm 25/200
368653 23 G (0.6 mm) 19 mm 305 mm 25/200
BD Vacutainer® Safety-Lok™ Blood Collection Sets with Pre-Attached Holder
Sterile closed system
Bloo
d co
llect
ion
4949
Safety blood collection needles
Safety shield aligned with needle bevel with no further
visual checks
Reduce blood exposure with blood exposure that pulls away
blood from the end of the needle
In-vein confirmation results in ease of use and confidence during venous
blood collection
Ergonomics to improve everyday use with anti-slip
finger grips and ribbed holder
Reduce needlestick injuries with thumb pad for single step safety activation and audible lock confirmation
Minimal waste with a simple peel to enable
the sterile needle
Efficiency in use and minimal waste with a simple peel to enable the sterile needle.
Immediate confirmation of venous access is indicated by the presence of blood in the flashback chamber.
4 5
Oxford OX4 4DQTel: 01865 748844Fax: 01865 781528Email: [email protected] www.bd.com/uk
Minimal waste
Blood droplet reduction technology draws blood away from the end of the needle.
Reduced risk
BD InstaFlash™ Needle Technology instantly signals vein entry for improved first stick proficiency.
Confirmation
5050
BD Vacutainer® Eclipse™ Signal™ Blood Collection Needle
The BD Vacutainer® Eclipse™ Signal™ needle offers a combination of proven robust safety technology with the additional benefit of in-vein confirmation built into an integrated ergonomic holder. This results in ease of use and confidence during venous blood collection, increasing both
Cat. no. Size Needle length Colour code Box/Case
368835 21 G (0.8 mm) 25 mm 50/400
368836 22 G (0.7 mm) 25 mm 50/400
Cat. no. Size Needle length Colour code Box/Case
368837 21 G (0.8 mm) 25 mm 50/500
368838 22 G (0.7 mm) 25 mm 50/500
Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use Holder is used.
Clinical and technical information is available on request.
Safety blood collection needles
BD Vacutainer® Eclipse™ Signal™ Blood Collection Needles
BD Vacutainer® Eclipse™ Signal™ Blood Collection Needles with Integrated HolderBl
ood
colle
ctio
n
5151
Safety blood collection needles
BD Vacutainer® Eclipse™ Blood Collection Needle
The BD Vacutainer® Eclipse™ safety needle for venous blood sampling has a fully integrated safety shield, which once activated, protects against needle stick injuries. This safety shield is an integral part of the needle and its orientation aligns with the needle bevel. The safety mechanism is designed for single-handed activation. The fully integrated safety shield engages over the needle with an audible click, irreversibly locking with a triple closure mechanism.
Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use Holder is used.
Clinical and technical information is available on request.
BD Vacutainer® Eclipse™ Blood Collection Needles
Cat. no. Size Needle length Colour code Box/Case
368609 21 G (0.8 mm) 32 mm 48/480
368610 22 G (0.7 mm) 32 mm 48/480
BD Vacutainer® Eclipse™ Blood Collection Needle with Pre-Attached Holder
With this safety needle the holder is already pre-attached, so it is not necessary to manually assemble the needle and holder. This ready-for-use blood sample needle and holder is individually packaged in a sterile blister.
BD Vacutainer® Eclipse™ Blood Collection Needles with Pre-Attached Holder
Cat. no. Size Needle length Colour code Box
368650 21 G (0.8 mm) 32 mm 100
368651 22 G (0.7 mm) 32 mm 100
5252
Cat. no. Size Needle length Colour code Box/case
360215 20G (0.9mm) 38mm 100/1000
360214 20G (0.9mm) 25mm 100/1000
360213 21G (0.8mm) 38mm 100/1000
360212 21G (0.8mm) 25mm 100/1000
360211 22G (0.7mm) 38mm 100/1000
360210 22G (0.7mm) 25mm 100/1000
BD Vacutainer® blood collection needlesBD Vacutainer® needles can be used for multiple tube samples. BD Vacutainer® needles are coated with silicone, a low friction lubricant, ensuring smooth vein entry.
BD Vacutainer® needles are available in 20, 21 or 22 gauge needle sizes.
Further information
BD recommends for all needles without an integrated holder that a BD Vacutainer® One Use holder is used.
Clinical and technical information is available on request.
BD Vacutainer® multi-sample needles
Bloo
d co
llect
ion
5353
3
1
2
4
AccessoriesAdapter and holder
BD Vacutainer® One Use holder, BD luer adapters and adapters with pre-attached holders
1 The BD Vacutainer® Blood Transfer Device is a pre-assembled and easy-to-use device designed with safety in mind. It is used for needleless specimen transfer from a syringe to an evacuated tube or blood culture bottle and has a red colour-coded connection to provide easy differentiation from other holder based products.
2 The BD Vacutainer® Luer-Lok™ Access Device is a pre-assembled multi-sample BD Luer-Lok™. It is compatible with female luer connections. It has a blue colour-coded connection to provide easy differentiation from other holder based products.
3 The BD Vacutainer® One Use holder is compatible with all BD Vacutainer® tubes and needles. The One Use holder is also compatible with the BD BACTEC™ blood culture bottle.
4 The BD Vacutainer® Luer adapter is a sterile device to be used with a One Use holder. It is compatible with female luer connections. It has a blue colour-coded cap to provide differentiation from other needles.
BD Vacutainer® One Use holder
Cat. no. Description Box/case
364815 BD Vacutainer® One Use plastic holders for tubes with 13mm and 16mm diameter and for BD BACTEC™ blood culture bottles, transparent white 250/1000
BD Vacutainer® Luer adapter
Cat. no. Description Colour code box/case
367300 BD Vacutainer® Luer adapter 100/1000
BD Luer adapters with pre-attached holdersThese single-use products are ready to use, sterile, packed individually with a unique device identified by a GS1 DataMatrix 2D bar code in a strip of six units.
Order no. Cat. no. Description Colour code Case
36481000 364810 Blood Transfer Device (“female Luer”) 198
36490200 364902 Luer-Lok™ Access Device (“male Luer”) 198
Other BD Vacutainer® holders
Cat. no. Description Colour code box/case
368872 BD Pronto™ Quick Release holder for tubes with 13mm and 16mm diameter and for BD Bactec™ blood culture bottles various 20/100
364879 BD Vacutainer® Multiple use plastic holder for tubes with 13mm and 16mm diameter and for BD Bactec™ blood culture bottles 250/1000
5454
AccessoriesStretch tourniquets
NEW
Cat. no. Description Case
367218 BD Pronto™Reusable Tourniquet 6
BD Vacutainer® Tourniquets
Blood Dispenser
Cat. no. Description box/case
366005 DIFF-SAFE®* 100/1000
DIFF-SAFE®
BD Vacutainer® Preanalytical Systems offers the DIFF-SAFE® blood dispenser for preparing blood slides from a blood collection tube.
BD Vacutainer® Stretch Tourniquet
The BD Vacutainer® Stretch Tourniquet is latex and scent-free, and is packaged in an easy-to-use dispenser which is also convenient for storage purposes.
Additional features include:
• Textured thermoplastic elastomer provides a better grip
• High visibility colours to increase contrast and minimise the chances of tourniquets being left on the patient arm or being incorrectly disposed of.
IMPROVED TEXTURE
*DIFF-SAFE® is a registered trade mark of Alpha Scientific Corporation
DIFF-SAFE®
Cat. no. Description Colour Box/Case
367198 25 new textured, single-use, latex-free tourniquets in one packaging unit, perforated for separation. Blue 25/500
367209 25 new textured, single-use, latex-free tourniquets in one packaging unit, perforated for separation. Orange 25/500
BD Vacutainer® Stretch Tourniquets
Bloo
d co
llect
ion
5555
Capillary blood samplingSafety lancets
Finger tip sampling
The ergonomic design of the BD Microtainer® Contact-Activated safety single-use lancet enables it to be held securely and the sampling point precisely located. The lancet has been clinically demonstrated to minimise patient discomfort and maximise blood flow.1,2
Its intuitive handling requires minimum training. The lancet is activated by being pressed onto the sampling location, minimising the influence of the user on puncture depth. The sharp point then retracts automatically into the housing.
This lancet is available in three sizes: for a single drop of blood, a medium or large flow of blood.
Further information
Clinical and technical information is available on request.
BD Microtainer® Contact-Activated Lancets
Cat. no. Piercing width and depth Blood volume Colour code Box/case
366592 30G x 1.5mm One drop 2000 (10 x 200)
366593 21G x 1.8mm Medium blood flow 2000 (10 x 200)
366594 1.5mm x 2.0mm Large blood flow 2000 (10 x 200)
Glucose monitoring
For filling a hematocrit tube
For filling BD Microtainer® tubes
1. BD White Paper VS7499: A Comparison of BD Microtainer® Contact-Activated Lancet (Low Flow, purple) with BD Microtainer® Genie™, LifeScan OneTouch® SureSoft™ Gentle, and SurgiLance™ One-Step PLUS Safety Lancets for Comfort, Ease of Use and Blood Volume, 2006
2. BD White Paper VS7607: A Comparative Evaluation of the BD Microtainer® Contact-Activated Lancet (High Flow, Blue) with Other Market-leading Lancets for Blood Flow and Ease of Use during Finger Puncture Procedures, 2008
5656
Capillary blood samplingSafety lancets
Heelstick sampling
The BD Microtainer® QuikHeel™ safety single-use incision lancet is for taking capillary blood samples from the heels of premature and new-born babies, and infants. When the button is pressed, an extra thin steel blade provides a fine, clean, surgical cut and ensures a good flow of blood. The penetration depth is pre-determined to protect against
bone infections and cannot be altered. The permanently shielded blade excludes the possibility of injury, or reuse.
The ergonomic design enables it to be held securely and the piercing point precisely located. The incision lancets are sterile and individually packed in blister packaging.
Further information
Technical information is available on request.
BD Microtainer® QuikHeel™ incision lancets
Cat. no. Description Piercing depth Piercing width Colour code Box/case
368102 Incision lancet for premature babies 0.85mm 1.75mm 50/200
368103 Incision lancet for newborn babies and infants 1.00mm 2.50mm 50/200
Capi
llary
blo
od sa
mpl
ing
5757
Capillary blood samplingBD Microtainer® MAP Tube
Process optimisation for capillary blood samples
BD Microtainer® MAP tubes are for collection, transport and processing of capillary blood from infants, children, geriatrics and emergency patients, whenever only the smallest amounts of blood are required.
The BD Microtainer® MAP tube for automated processing enables efficient workflow, both on the ward and in the laboratory.
• A capillary blood tube with standard blood collection tube dimensions (13 x 75 mm) and penetrable closure.
• Compatible with haematology analysers without the need for a tube adapter.
• Three clearly visible fill markings ensure the correct sample volume (250-500 µl).
• A standard label can be attached directly to the sample, minimising the risk of misidentification due to missing or incomplete labelling.
• Easy to open with twist locking mechanism that ensures no leakage.
• Colour marking for identification of the type of sample and the correct positioning of the patient label.
Further information
Technical information is available on request.
BD Microtainer® MAP Tube
Cat. no. Description Closure Cap colour Box/Case
363706 K2EDTA tube for haematology with full size blood collection tube, dimensions 13 x 75 mm BD Microgard™ 50/200
Automated processing
enables efficient
workflow
Order of draw and recommended inversions for BD Microtainer®
Order of draw EDTA PST™ LH Glucose SST™ Z (without additive)
Recommended inversions x8 x10 x10 x10 x5 x5
5858
Capillary blood samplingBD Microtainer® tubes
BD Microtainer®
BD Microtainer® tubes are for collection, transport and processing of capillary blood from infants, children, geriatrics and emergency patients, whenever only the smallest amounts of blood are required.
In order to ensure tube identification, the tubes are marked with the colour code that corresponds to the venous blood collection tubes. There are fill marks on the tubes that ensure the correct blood to additive ratio.
BD Microgard™ closure
The special design of the BD Microgard™ safety closure substantially reduces blood splashing after the tube has been opened.
A larger diameter facilitates handling of the tube.
In combination with a tube extender, the BD Microtainer® tubes with BD Microgard™ closure fit into 13 x 75mm racks.
Tube mixing
BD Microtainer® EDTA and glucose tubes should be gently inverted 180° and back 5 times.
BD Microtainer® plasma tubes should be gently inverted 180° and back 8-10 times.
BD Microtainer® SST™ tubes should be gently inverted 180° and back 8-10 times.
Further information
Technical information is available on request.
Cat. no. Description Fill volume Closure Cap colour Box/case
365975 K2EDTA tube for haematology 250-500 µl BD Microgard™ 50/200
365966 Plasma tube with lithium heparin 200-400 µl BD Microgard™ 50/200
365986 Plasma tube with separating gel and lithium heparin 400-600 µl BD Microgard™ 50/200
365988 Plasma tube with separating gel, lithium heparin and UV protection (amber tint for light sensitive tests e.g. bilirubin) 400-600 µl BD Microgard™ 50/200
365993 Glucose tube with sodium fluoride and Na2EDTA 400-600 µl BD Microgard™ 50/200
365968 Serum tube with separating gel 400-600 µl BD Microgard™ 50/200
365979 Serum tube with separating gel and UV protection (amber tint for light sensitive tests e.g. bilirubin) 400-600 µl BD Microgard™ 50/200
365964 Serum tube without additive 250-500 µl BD Microgard™ 50/200
368933 BD Microtainer® tube extender for attachment to all BD Microtainer® tubes with BD Microgard™ closure (10mm diameter) n/a n/a 50/200
BD Microtainer® tubes with Microgard™ closure
Capi
llary
blo
od sa
mpl
ing
5959
BD Critical Care Collection SyringesBlood gas syringes
BD Critical Care collection syringes can be used to collect blood from a patient’s artery or vein. All syringes contain spray-dried calcium-balanced Lithium Heparin that enables the specimen to be analysed for Arterial Blood Gases (ABGs) and a host of critical care analytes.
Further information
Clinical and technical information is available on request.
Safety cap
Luer-Lok™ 3 mL syringes areequipped with a safety cap typeBD Hemogard™, green in color: - Minimizes contact with blood- Covers entirely the syringe tip- Large size for good grip and easy handling- Safe closure
BD A-Line™ blood gas sy ringes
BD A-Line™ syringes are used for blood collection by manual aspiration and are supplied without needles. They are designed to be used for arterial or venous blood collection from an arterial or IV line, and are available in 1mL and 3mL slip tip and 3mL BD Luer-Lok™ syringes.
Syringes supplied in cases of 100
* Spray dried, calcium-balanced lithium heparin
BD A-Line™ blood gas syringes
Cat. no. Syringe volume (mL)
Recommended fill volume (mL)
Units of heparin* (IU)(per syringe) Gauge Needle length Connection Tip cap
364356 1.0 0.6 30 - - Slip tip Conventional
364378 3.0 1.6 80 - - BD Luer-Lok™ Hemogard style
364376 3.0 1.6 80 - - Slip tip Conventional
6060
BD Critical Care Collection SyringesBlood gas syringes
BD Preset™ safety blood gas syringe
BD Critical Care Collection syringes are available with the BD Eclipse™ safety-engineered needle, offering enhanced safety for the healthcare worker. The safety shield is integrated and is not an accessory to the needle. The needle bevel and safety shield are in alignment, ensuring no extra manipulation. The single-handed technique ensures no change in the collection technique and the double-locking mechanism is both visually and audibly confirmed for the healthcare worker.
Further information
Clinical and technical information is available on request.
Eclipse™ safety technology: Single-handed activation
Audible clickIrreversibly locking
BD Preset™ safety blood gas syringes
Cat. no. Syringe volume (mL)
Recommended fill volume (mL)
Units of heparin* (IU)(per syringe) Gauge Needle length Connection Tip cap
364390 3.0 1.6 80 22G (0.7mm) BD Eclipse™ 1” (25mm) BD Luer-Lok™ Hemogard style
364391 3.0 1.6 80 23G (0.6mm) BD Eclipse™ 1” (25mm) BD Luer-Lok™ Hemogard style
364393 3.0 1.6 80 25G (0.5mm) BD Eclipse™ 1” (25mm) BD Luer-Lok™ Hemogard style
Syringes supplied in cases of 100
* Spray dried, calcium-balanced lithium heparin
Syringes supplied in cases of 100
BD Preset™ blood gas syringe
The BD Preset™ syringe plunger can be preset to the recommended volume. As arterial blood fills the syringe, the residual air is expelled through the self-venting membrane.
Cat. no. Syringe volume (mL)
Recommended fill volume (mL)
Units of heparin* (IU)(per syringe) Gauge Needle length Connection Tip cap
364416 1.0 0.6 30 - - Slip tip Conventional
364316 3.0 1.6 80 - - BD Luer-Lok™ Hemogard style
364413 1.0 0.6 30 23G (0.6mm) 1” (25mm) Slip tip Conventional
364415 1.0 0.6 30 25G (0.5mm) 5/8” (16mm) Slip tip Conventional
364314 3.0 1.6 80 22G (0.8mm) 1” (25mm) BD Luer-Lok™ Hemogard style
364327 3.0 1.6 80 23G (0.5mm) 1” (25mm) BD Luer-Lok™ Hemogard style
BD Preset™ blood gas syringes
Arte
rial b
lood
sam
plin
g
6161
BD Vacutainer® Urine Collection System
BD Vacutainer® Urine Collection System is a closed system offering a range of solutions for collection, transport and preservation of urine samples to meet the needs of each patient according to their age, health and mobility.
BD offers a wide range of tube volumes for microbiology and urinalysis determinations, with or without preservatives. For microbiology determinations, BD offers a range of tube types with boric acid based preservatives, all clinically validated to provide 48 hour specimen stability at room temperature.1,2,3
BD collection devices include specimen cups, 24 hour 3L containers and transfer straws for all patient collection methods.
Once sampled from the various patient collection sites, the BD evacuated urine tubes can be safely transported to the laboratory for analysis.
Further information
Clinical and technical information is available on request.
Cat. no. Draw volume (mL) Size (mm) Additive Material Label Cap closure Cap colour Box/case
368500 4.0 13 x 75 Without additive PET Paper BD Hemogard™ 100/1000
368501 6.0 13 x 100 Without additive PET Paper BD Hemogard™ 100/1000
365000* 9.5 16 x 100 Without additive PET Paper BD Hemogard™ 100/1000
364938 10.0 16 x 100 Without additive PET Paper Conventional 100/1000
364915 11.0 16 x 100 Without additive PET Paper BD Hemogard™ 100/1000
365017 8.0 16 x 100 Stabiliser** mercury free PET Paper BD Hemogard™ 100/1000
Urine collection products
BD Vacutainer® tubes for urinalysis
* With conical bottom** With stabiliser (chlorhexadine, ethyl paraben and sodium propionate) 1. Kouri T, Vuotari L, Pohjavaara S, Laippala P. Preservation of Urine for Flow Cytometric and Visual Microscopic Testing. Clin. Chem., Jun 2002; 48: 900-9052. BD White Paper VS7097: Evaluation of BD Vacutainer® Urine Culture & Sensitivity PLUS Tube vs. Refrigerated BD Vacutainer® Non-Additive PLUS Tube for Microbiological Testing - Seeded Urine, 20033. BD White Paper VS7099: Evaluation of BD Vacutainer® Urine Culture & Sensitivity PLUS Tube vs. BD Vacutainer® Urine Culture & Sensitivity Glass Tube for Microbiological Testing - Patient Urine, 2003
6262
Further information
Clinical and technical information is available on request.
1 Wenger JE. Cultivating quality: reducing rates of catheter-associated urinary tract infection. Am J Nurs. 2010;110(8): 40-5
* Includes urine transfer straw
** Stabiliser for microbiological investigations consisting of boric acid, sodium formate and sodium borate, up to 48 hours stabilisation of bacteria growth at room temperature.1,2,3
Urine collection products
Cat. no. Draw volume (mL) Size (mm) Additive Material Label Cap closure Cap colour Box/case
364958 4.0 13 x 75 Stabiliser** PET Paper BD Hemogard™ 100/1000
364955 10.0 16 x 100 Stabiliser** PET Paper BD Hemogard™ 100/1000
BD Vacutainer® Urine tubes for microbiology
Cat. no. Draw volume (mL) Size (mm) Additive Material Label Cap closure Cap colour Box/case
364959* 4.0 13 x 75 Stabiliser** PET Paper BD Hemogard™ 50/200
364944* 10.0 16 x 100 Stabiliser** PET Paper BD Hemogard™ 50/200
BD Vacutainer® kits for microbiology
Cat. no. Description Pack/case
364941 Polypropylene urine cup with screw closure and integrated transfer device, capacity 120mL, sterile 200
364982 Coloured polypropylene 24 hour collection container for the protection of light sensitive analytes, with screw closure and integrated urine transfer device, capacity 3 litres, with scale for volume checking, non-sterile 40
364940 Specimen transfer straw, non-sterile 100/1000
36490200 Luer-Lok™ Access Device (male luer) 198
BD Vacutainer® Urine collection containers and transfer units
The BD Vacutainer® Luer-Lok™ Access Device enables transfer of a urine sample directly from a Foley catheter to the tube. It enables fewer sample collection steps, less manipulation and reduced risk of contamination.1
Urin
e co
llect
ion
prod
ucts
6363
TransportMoveBag & MoveBox system for interlaboratory transportation
The biological specimen transportation system ensures your laboratory complies with international regulations:
• ISO 15189
• International Carriage of Dangerous Goods by Road (ADR) 2011 including packaging instructions P650 for UN3373 products
• UNI EN 829/98 Pressure resistance test & Drop Test
Cat No. Description Unit of sales
368705 Tube rack for 13mm tubes, fits 77 tubes 24 racks
367218 Tube rack for 16mm tubes, fits 77 tubes 24 racks
368711 Absorbent - size: 200 x 120 mm 100 pieces
Tube Racks and Absorbents
Cat No. Description Unit of sales
368704 Box - Blue transparent 12 boxes
368702 MoveBox + tube rack for 13 mm tubes + 2 absorbants 12 boxes
368703 MoveBox + tube rack for 16 mm tubes + 2 absorbants 12 boxes
MoveBox
6464
TransportMoveBag
Cat No. Description Dimensions (external) Unit of sales
366911 Isothermic MoveBag, for 2 Movebox, navy blue 305 x 210 x 270 mm 2 bags
368701 Isothermic MoveBag, for 4 Movebox, navy blue 390 x 280 x 270 mm 2 bags
Cat No. Description Unit of sales
368700 MoveBag + 4 MoveBox with tube rack for 13mm tubes and 2 absorbants 2 kits
MoveBox and MoveBag Kit
MoveBag for Phlebotomists
Cat No. Description Dimensions (external) Unit of sales
361581 Isothermic MoveBag, red, adjustable compartments 450 x 280 x 280 mm 2 bags
Cat No. Description Weight Unit of sales
368707 Eutectic system to stabilize temperature at 22° 0.2 kg 12 units
368708 Eutectic system to stabilize temperature at 22° 1.1 kg 6 units
368709 Eutectic system to stabilize temperature at 4° 0.2 kg 12 units
368710 Eutectic system to stabilize temperature at 4° 1.1 kg 6 units
Temperature Packs
Example of how the MoveBag for Phlebotomists can be organized All shown items are seperately available
Tran
spor
t
6565
Product compliance
BD Vacutainer® Blood Collection Tubes and ancillary equipment are In-Vitro Diagnostic Medical Devices, non Annex II. These comply with the requirements described in the European In Vitro Diagnostic Medical Device Directive 98/79/EC.
BD Vacutainer® Eclipse™ Signal™ Blood Collection Needles, BD Vacutainer® Push Button Blood Collection Sets, BD Safety-Lok™ Blood Collection Sets, BD Microtainer® Contact-Activated Lancets and Critical Care Collection Syringes with needles are class IIa Medical Devices and as such, comply with the requirements of the European Medical Device Directive, 93/42/EEC.
All product unit labels (and most packaging levels) bear the CE mark, demonstrating conformity to the above Directives.
The UK manufacturing plant, which supplies most European product, is certificated to ISO 13485 and ISO 14001. As a supplier to the U.S. market, the plant is also subject to FDA inspection and therefore holds an FDA establishment registration certificate. Copies of all these certificates can be provided upon request.
Other BD manufacturing plants carry similar certification, which can also be provided upon request.
All products are designed and manufactured in accordance with the relevant international and/or European standards.
The product shelf life is based on data from stability testing and varies according to specific products. All expiry dates are clearly printed on product unit labels.
Clinical data
Prior to launching a new product, BD conducts extensive clinical testing.
Whenever changing any manufacturer’s blood collection tube type, size, handling, processing or storage condition for a particular laboratory assay, the laboratory personnel should review the manufacturer’s tube specifications to establish/verify the reference range for a specific instrument/reagent system. Based on such information, the laboratory can then decide if a change is appropriate.
Product sterilisation
All products, where applicable, are sterilised using either gamma irradiation, ethylene oxide (EtO) or moist heat methods. Microbiological environmental assessment for bio-burden levels is conducted regularly.
The sterilisation of BD Vacutainer® products is controlled by European standards:
EN ISO 11135 Sterilization of health care products -- Ethylene oxide -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
EN ISO 11137 Sterilization of health care products -- Radiation -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
EN ISO 17665 Sterilization of health care products -- Moist heat -- Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices
EN 556 Requirement for terminally sterilised devices to be labelled “STERILE”
Additional informationProduct quality statement
666666
Additional information
Veno
us b
lood
sam
plin
gAd
ditio
nal i
nfor
mat
ion
The abbreviations used in this catalogue have the following meanings: PU = Packaging unit G = Gauge RT = Room temperature RCF = Relative centrifugal force g = g-number IVD = in vitro diagnostics
0 0 8 6 0 0 5 0
The CE mark, signifying compliance with the European IVD MD Directive, 98/79/EC or the MD Directive 93/42/EEC.
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Catalogue orre-order number
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Lot number or batch number
Use by, expires
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Use once or do not reuse
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Sterilised bymoist heat
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Sterile fluid path. Sterilised by irradiation
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Sterilised by irradiation
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Sterilised by Ethylene Oxide gas
Keep away from sunlight (may show temperature range)
Protect from any light source
Fragile
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Storage temperature range
This way up
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Recycle
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Date of manufacture
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Serial numberFrequently Used
SymbolsHandling & Storage
Symbols Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
“Caution” - consult instructions for use for important cautionary information
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Keep dry
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Manufacturer
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
In vitro diagnostic medical device
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXXConsult instructions for use
Frequently UsedSymbols
Handling & StorageSymbols
Hazard Symbols
Misc. Symbols
Recycle Symbols
F-Flammable
T-Toxic
XXXX
Authorised representative in the EU community
Non-Pyrogenic Do not use if packaging is damaged
K2E EDTA - dipotassium salt
K3E EDTA - tripotassium salt
N2E EDTA - disodium salt
9NC Trisodium citrate 9:1
4NC Trisodium citrate 4:1
FX Fluoride/Oxalate
FE Fluoride/EDTA
FH Fluoride/Heparin
LH Lithium heparin
NH Sodium heparin
Z None (no additive)
676767
Additional informationLabelling and packaging information
Case
Labelling is only for BD Barricor™ example.
Box
Tube Labelling
Fill volume
Fill marking
BD catalogue number
BD Vacutainer® notch label - colour codingand attachment point for secondary label
Type of tube and additive concentration (if applicable)
Sterilisation symbol
Expiry date
Batch number
1 2
34
567
Type of tube and additive concentration (if applicable)Instructions for use as pictograms BD catalogue numberNumber of tubes in the boxExpiry date and batch numberApplicable symbolsCountry of originVolume and size of the tubes
1
2345678
Type of tube and additive concentration (if applicable)BD catalogue numberNumber of tubes in the case Applicable symbolsCountry of originVolume and size of the tubes
1
23456
1
3
4
56
7
88
1 2
34
5
6
78
12
3 4
56
Paper labelPatient data can be written directly onto the white surface of the standard label.
Block labelPaper label with form for patient data.
See ThruThe product specifications are printed directly onto the tube and enable better visual inspection of the tubes.
Transparent labelSame format as the paper label, but has the advantage that it is transparent and thus allows a better visual inspection of the tube.
2
686868
Additional informationProduct code index
PCN Page220245 43220246 43220532 43257283 42360210 53360211 53360212 53360213 53360214 53360215 53361017 32361545 31361546 31361547 31361548 31361549 31361550 31361555* 31361581 65362725 32362780 34362781 34362782 34362795 35362799 35363047 17363048 17363706 58364308 17364314 61364316 61364327 61364356 60364376 60364378 60364390 61364391 61364393 61364413 61364415 61364416 6136481000 54364815 54364879 5436490200 54364915 62364917 32364938 62364940 63364941 63364944* 63364955 63364958 63364959* 63364982 63365000* 62365017 62365900 29365904 18
PCN Page365964 59365966 59365968 59365975 59365979 59365986 59365988 59365993 59366005 55366016 31366164 32366420 37366421 37366422 36366444 21366448 36366468 21366566 21366567 28366575 17366592 56366593 56366594 56366644 21366645 33366666 31366674 31366676 31366882 21366911 65367198 55367209 55367218 64367246 48367247 48367282 48367284 48367286 48367288 48367295 48367300 54367323 46367324 46367326 46367335 46367336 46367338 46367341 46367342 46367344 46367354 47367355 47367363 45367364 45367365 45367374 28367376 28367378 28367391 45
PCN Page367392 45367393 45367525 29367526 23367614 18367624 18367714 17367735 33367740 31367756 33367764 30367811 19367817 19367819 18367836 29367862 29367864 29367869 23367876 23367896 18367941 32367953 21367955 21367957 21368102 57368103 57368201 30368271 18368272 23368273 17368274 29368380 33368381 33368383 48368480 23368492 18368494 23368496 23368497 28368498 21368499 29368500 62368501 62368520 30368521 30368609 52368610 52368650 52368651 52368652 49368653 49368654 49368655 49368657 47368658 47368684 45368685 45368686 45368687 45
PCN Page368688 45368689 45368700 65368701 65368702 64368703 64368704 64368705 64368707 65368708 65368709 65368710 65368711 64368774 19368814 18368815 18368817 32368835 51368836 51368837 51368838 51368841 29368856 29368857 29368860 29368861 29368872 54368879 21368884 23368886 23368889 23368920 30368921 30368933 59368965 21368966 21368967 21368968 21368969 21368970 21369032 18442003 42442020 42442021 42442022 42442023 42442026 42442191 42442192 42442193 42442194 42442206 42442260 42442265 42761165 40762165 39768165 38
Veno
us b
lood
sam
plin
gAd
ditio
nal i
nfor
mat
ion
696969
Fast diagnosis:Time saving:1. C. Ramakers, BD Barricor™ Scientific Forum, 20182. C. Fleming et Al., AACC Conference, 2018
Quality:Cleaner sample:3. BD White Paper VS9195, Evaluation of Specimen Quality in BD Vacutainer Barricor Tubes with Respect to Visual Observations and Cell Counts in Plasma as Compared with BD Vacutainer PST II Tubes.4. Padoana A., et al. Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation. Clinica Chimica Acta 483 (2018) 271–274.
Inert separation:5. Schrapp A., et al. The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator? Clinica Chimica Acta 488 (2019) 196-201. 6. Mazur C., Hayden J. The Becton Dickinson BarricorTM tube does not introduce isobaric interferences in mass spectrometry-based measurements of testosterone. JALM (2017).
Accuracy:Improved performance:5. Schrapp A., et al. The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator? Clinica Chimica Acta 488 (2019) 196-201. 7. BD White Paper VS9168-1-OUS, Comparison of the BD Vacutainer® Barricor™ Tube with the BD Vacutainer® PST™ II Tube and BD Vacutainer® Serum Tube for Selected Therapeutic Drugs. 8. Ramakers C. BD Vacutainer® Barricor™ tube in the emergency department: reduced hemolysis rates using partial draw tubes with reduced vacuum. Clin Chem Lab Med (2017).
Analyte stability:9. BD White Paper VS9295-1-OUS, Within-Tube Stability of Selected Routine Chemistry Analytes and Immunoassays in BD Vacutainer® Barricor™ Tubes in Comparison with BD Vacutainer® PST™ II and SST™ II
Advance Tubes at Multiple Time Points Post Centrifugation.10. BD White Paper VS9377-OUS, Within-Tube Stability of Lactate Dehydrogenase in BD Vacutainer® Barricor™ Tubes with Dark Gray Stopper, BD Vacutainer® PST™ II and BD Vacutainer® SST™ II Advance Tubes.11. Fleming C., Ramakers C. Transitioning from serum to plasma. EFLM Conference 2017.
Efficiency:Process control:2. C. Fleming et al., AACC Conference, 2018
Consolidation:12. Arslan F. D. et al. The local clinical validation of a new lithium heparin tube with a barrier: BD Vacutainer® Barricor LH Plasma tube. Biochemia Medica 2017.5. Schrapp A., et al. The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator? Clinica Chimica Acta 488 (2019) 196-201. 13. Füzery A. K. et. al. The BD Barricor blood collection tube is an acceptable and robust alternative to the PST for use with the Beckman AccuTnI+3 assay. Clinical Biochemistry 2017.14. BD White Paper, VS9236-1-OUS: Comparison of the BD Vacutainer® Barricor™ Tube with BD Vacutainer® PST™ II, BD Vacutainer® SST™ II Advance and BD Vacutainer® Serum Tubes for Selected Infectious Disease Assays.
7070
This product catalog is valid as of 2019, in Belgium, The Netherlands & Luxembourg
Technical changes, changes to the product range and printing errors are subject to change without notice.
©2019 BD. BD, BD logo and BD Vacutainer are trademarks of Becton, Dickinson and Company
WEU020.1
BD Life SciencesPreanalytical SystemsErembodegem-Dorp 869320 Erembodegem, Belgium
Tel: +32 53 720 556
www.bd.com [email protected]
BD Life SciencesPreanalytical SystemsLange Dreef 11,4131 NJ Vianen, The Netherlands
Tel: + 31 20 582 94 20
bd.com